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Steroids bonded to pharmaceutically active molecules are interesting candidates as 
therapeutic agents. In this work, a number of potentially bioactive residues, which include 
the quinoid moiety, have been synthesized as a simple steroid quinone hybrid, where the 
steroid component will be estradiol derived or the steroid cholesterol derived. For this 
purpose, two novel reactions have been explored namely, the modification of the APPEL 
reaction to connect residues by using PPh3/BrCCl3 for amidation and esterification of 
carboxylic acids. Another one is the hydrogenation reaction of alkenes by using NaBH4, 
AcOH, Pd/C and toluene or benzene in the presence of benzyl groups with hydrogen 
production in situ. The halogenation of residues that can be linked to steroids has also 
been attempted. The main aim of the proposal work is the development of a strategy that 
can be adopted for the radio-halogenation of the residues that function as potential radio-
diagnostic agents when linked to the steroid. 
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Title and Abstract (in Arabic) 
لة تحضير ستيرويدات مترافقة جديدة واستخدامها كعوامل تشخيصية وعالجية محتم
 الكينودات ذات الهالوجينات المتنوعةمع التركيز على 
 الملخص
ين كعوامل المرتبطة مع الجزيئات النشطة صيدالنيا وجدت اهتمام خاصا من قبل الباحثي الستيرويدات
والتي تشمل  عالجية. في هذا الدراسة، استخدمت  بعض المركبات الكيمائية  ذات  النشاط  البيولوجي،
ستراديول مكون الستيرويد سيكون احيث  بسيطة التركيب، رويداتكستيكينويد، تم تخليقها اصطناعيا 
ائية يت الكيمثنين من التفاعالإستخدام لهذا الغرض، تم ا .يمشتقة أو اشتقاق الكوليسترول الستيرويد
وأسترة األحماض ضافة األميد إو 3BrCCl/3PPh ستخدامإوهي تعديل للتفاعل ب الجديدة
ين والتولو AcOH4NaBH ,Pd/C , ,ستخدام إهدرجة األلكينات بهو تفاعل خر، و اآلالكربوكسيلية
قد  ذلك، ىإلضافة إ. البنزايل مع إنتاج الهيدروجين في الموضع نفسه مجموعاتأو البنزين في وجود 
و وضع هوالهدف الرئيس من هذا الدراسة لستيرويدات. بالمشتقات المهلجنة الربط  جريت محاوالتأ
لتشخيصية شعة األلة من المخلفات التي تعمل كعوامل ععالهلجنة المشفي ستراتيجية يمكن اعتمادها إ
 .   مع بعضها اتعندما ترتبط الستيرويد
ل العالجية، ات، العوامكينويد، الستيرويدات : المركبات العضوية المخلقة،الرئيسية البحث مفاهيم
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Chapter 1: Introduction 
1.1 Steroids-Bioactive Linkage 
Hybrids of biomolecules and bioactive residues or residues with diagnostic 
markers have become of great interest in diagnosis and therapy. In the steroidal field, 
steroids have been linked to cancer-active residues (Bansal and Acharya 2014), and they 
have been either radiolabeled within their steroidal framework or have been connected to 
a moiety that itself has been radiolabeled. It is hoped that the derivatised steroid interacts 
with the receptor of the natural, non-derivatised steroid. At that time, the bioactive residue 
would “perform its work” or the radiolabel would send its signal to help localize the 
molecule within the tissue.  
There exist diseases where certain natural receptors are overexpressed. One such 
receptor is the estrogen receptor ERα. Over the years, a number of estradiol derived 
steroids connected to bioactive molecules have been published. These include conjugates 
with mustards, eg. 1 and 3 (Vollmer et al. 1973; Mitra et al. 2002), nitrosourea 2(Lam et 
al. 1979), and platinum complexes such as 4 (Georgiades et al. 1987; Perron et al. 2004) 
and estradiol has been connected to ellipticinium 5 (Delbarre et al. 1985) (Scheme 1). 
Also, estradiol has been connected to nucleosides and nucleotides such as 6 and 7(Ali et 
al. 2006; Iyer et al. 1983) (Scheme 2). 
In all of these cases, the estradiol component is used as a drug delivery system, 
ultimately not only bringing the bioactive component to the right tissue but oftentimes 
into the nucleus of ER- overexpressed cells. It is believed that in 60-70% of all breast 
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Analogous is the reasoning behind using radiolabelled estradiol derivatives as 
diagnostics and therapeutics (Al Jasem et al., 2016; Oliveira et al, 2012; Oliveira et al., 
2013, Cunha, 2013). Here, the steroid is equipped with a radiolabel that emits gamma 
radiation of a certain energy that can be detected. Typical radiotracers used are 123I for 
Single Photon Emission Computed Tomography (SPECT), 18F for Positron Emission 
Tomography (PET) and 99mTc (SPECT). All of these have been studied, when attached to 
an estradiol derivative. 18F-derived steroids used for diagnostic purposes have been 
studied in clinical trials, already (Mintun et al. 1988, McGuire et al. 1991, Deshdashti et 
al. 1995). 
The most important derivatives to date are 16-[18F]fluoroestradiol[18F]FES and 
11βmethoxy-4,16-[18F]difluoroestradiol (4F-M[18F]FES) (Scheme 3). Radiolabelled 
steroids can also be used in therapy. In principle, here not only emitted gamma radiation 
is used, but also emitted Auger electrons. One possible radionuclide for Auger therapy 
(Kassis 2003) is [77Br] bromine and [125I] iodine (Bodei et al. 2003). Thiemann group has 
already worked in collaboration with the Instituto Tecnológico e Nuclear, Instituto 
Superior Técnico, Universidade de Lisboa in Sacavem, Portugal with 99mTc and 123I-



















Scheme 3: [18F]FES as PET diagnostic agents 
 
1.1.1 Steroids-Quinones Linkage 
 
Scheme 4: Steroid derived quinone and mimic quinone hybrids (Delbarre, 1985) 
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Quinones are distributed widely in living organisms. Some of the more familiar 
ones are plastoquinone and phylloquinone, both quinones needed in photosynthesis, and 
ubiquinone, also known as coenzyme Q10, which participates in the aerobic cellular 
respiration. The entire above are substituted p-benzoquinones. Anthracyclines can be 
viewed as having a quinoid group. A number of members of this family such as 
daunorubicin and doxorubicin are used in cancer chemotherapy. Also menadione (2-
methylnaphtho-1,4-quinone), which is sold as a nutritional supplement as a vitamin K 
mimic, has been viewed as a potential drug for prostate cancer treatment (Jamison 2001). 
Overall, in 1991, quinones constituted the second largest group of cytotoxins used in 
chemical cancer therapy, after specifically alkylating agents such as mustards (O’Brien 
1991), with about 1500 quinones already tested in 1974 (Driscoll et al. 1974).  
Quinones have a number of actions in the body. In strongly dividing cells, their 
most influential action is the interaction with DNA material, which may lead either to 
DNA damage or to change DNA resulting in cell mutations (O’Brien 1991). In non-
dividing cells or in cells at rest the main action of the quinones is a possible alkylation of 
proteins through their thiol or amino groups (O’Brien 1991). Most important, though, is 
the reduction of the quinones to the respective semi-quinone radicals by reductase. The 
semi-quinoneradicals in turn reduce oxygen to superoxide radicals and reform as 
quinones. The superoxide radicals, which are usually scavenged in the body by the 
enzyme superoxide dismutase, are very toxic and lead among others the oxidation of 
cysteine residues to cysteine in proteins and the oxidation of glutathione (GSH) to 
glutathione disulphide (GSSG) as stated by O’Brien, 1991.  
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It has been found that the protein NAD(P)H: quinone oxidoreductase 1 (QR1) is 
overexpressed in many human solid tumours such as adrenal, thyroid, breast, ovarian, 
colon, and non-small-cell lung cancer (Siegel and Ross 2000). This enzyme poses a 
possible target for quinone drugs. Recently, the crystal structure of the protein complex 
to different synthetic quinones has been published (Falg et al., 2001). Among other details, 
it had been shown that the protein is relatively flexible to ligand differently substituted 
quinones, which may bind to QR1 in different orientations. 
With the known cancer activity of anthracyclines, anthracyline-steroid hybrids 
(Dao et al., 2012) such as 16 (Scheme 4) (Hartman et al., 1990) were synthesized and 
their biological activity was investigated. These studies were extended to dihydroxy-
arenoquinone containing steroids such as 10,11and 12 (de Riccardis et al., 1997; de 
Riccardis et al., 1998), then to quinoid containing steroid 13 (Fujiwara et al., 2011), and 
steroidal mimic 14 (Kaliappan & Ravikumar, 2005). Thiemann group had communicated 
the annealed steroidal anthraquinone 15 previously (Morais et al., 2005). In this thesis, a 
pathway is to be found for a facile synthesis of steroid quinone hybrids, where the steroid 
component will be estradiol derived foreasy accessibility of the steroid cholesterol 
derived. 
1.2 Brominated Steroids: SPECT Imaging Agents 
76-Bromine, 77-bromine, 78-bromine isotopes are Auger-electron emitters. The 
Auger electron emitters often decay with sufficient positron emission, so that they can 
also be used as agents for positron emission tomography (PET). This can be used to 
complement diagnosis with therapy (DeSombre et al. 1988; DeSombre et al. 1992; Kassis 
7 
 
et al. 1982). The life-time of 76-bromine is sufficiently long that it will allow for a target-
tissue selective biodistribution, but sufficiently short that much of it will have decayed in 
the cell before metabolism and excretion of the compound.  
The synthesis of a number of estradiols labeled with SPECT radionuclide 
bromine-77 have been reported (McElvany et al. 1982, Senderoff et al. 1982, 
Katzenellenbogen et al. 1981, Katzenellenbogen et al. 1982). Some of these have been 
evaluated both in animals and in humans. Their use in imaging has been limited to date, 
however. Especially, 16α-[77Br] estradiol has been reported to have potential as SPECT 
















17 18 19  
Scheme 5: [76Br]-Bromo-labelled steroids as Auger emitters 
 
More recently, 16, 17-[(R)-1’--(5-[76Br]bromofurylmethylidene)dioxyl]-21-
hydroxy-19-norpregn-4-ene-3,20-dione (19) has been synthesized and its biodistribution 
been studied in immature Sprague-Dawley rats. It showed progesterin receptor (PR) 
mediated uptake. The biodistribution was found to be favorable, but its metabolism was 
too rapid (Zhou et al. 2008). While radio-brominated steroidal estrogens and progestins 
have been prepared, the study of these compounds is still limited by their poor 
accessibility. Thus, knowledge of radiobrominated steroids is much less advanced than 
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that of radioiodinated or radiofluorinated steroids. In this work, the bromination of a 
prosthetic group that will be linked to the steroidal system is to be studied. This is to show 




















Chapter 2: Methodology 
2.1 Introduction 
    Initially, modification of two synthetic reactions was needed. The first reaction 
was an Appel-type linkage of an acid to a second moiety via an ester or amide function. 
Here, the reaction was carried out with the new reagent triphenyl-phosphine-bromo-tri-
chlorocarbon (PPh3-BrCCl3). A number of amides and esters were synthesized in order to 
optimize this type of reaction for the target products. The second reaction was the 
hydrogenation of a double bond using sodium borohydride (NaBH4), acetic acid (AcOH) 
and palladium on carbon (Pd/C), this reaction was also used to O-debenzylateO-
benzylarenes, albeit under forced conditions. In order to understand how to control 
alkene-hydrogenation over reductive O-debenzylation, a number of O-benzylcinnamates, 
O- and N-benzyl-cinnamamides were tested under different reaction conditions. The 
products from the reactions above were characterized by 1H NMR (400 MHz) 
spectroscopy, 13C NMR (100.5 MHz) spectroscopy, IR and melting point. 
Next, a number of 1,4-dimethoxy-phenyl-propionates and 1,4-dimethoxy-phenyl-
propionamides, obtained from the reactions above, were treated with cerium ammonium 
nitrate (CAN) in order to acquire the corresponding quinones. Also, a variety of 3-
hydroxy-4-methoxyphenylpropionates and 3-hydroxy-4-methoxypropionamides were 
subjected to oxidation with CAN and transformed to methoxyquinonylpropinates and 
methoxyquinonylpropionamides. The products from the reactions above were 
characterized by 1H NMR (400 MHz) spectroscopy, 13C NMR (100.5 MHz) spectroscopy, 
IR and UV-VIS spectroscopy, and melting point. 
10 
 
Cholesterol was esterified with 1,4-dimethoxyphenylpropionic acid, with 2,5-
dimethoxybenzoic acid and with 3-hydroxy-4-methoxyphenylpropionic acid under the 
modified Appel conditions, developed by us. 3-O-Methylestradiol was reacted with 1,4-
dimethoxypropionic acid under these conditions, also. These steroidal esters were reacted 
with CAN to give the corresponding quinone-steroid hybrids. The steroid-quinone 
hybrids were characterized by 1H NMR (400 MHz) spectroscopy, 13C NMR (100.5 MHz) 
spectroscopy, IR and UV-VIS spectroscopy, and melting point.  
Finally, 3-hydroxy-4-methoxyphenylpropionamides prepared were brominated 
with N-bromosuccinimide (NBS) in DMF to investigate the ease of monobromination for 
the purpose of linking the 3-hydroxy-4-methoxyphenylpropionyl function to a steroidal 
alcohol or amine as a prosthetic group and attaching a bromo-label selectively to a 
prosthetic group. A sample, cinnamaldehyde oxime, was sent out to the Department of 
Inorganic Chemistry, University of Hamburg, for X-ray structural analysis. The 
cinnamaldehyde was to be used to test the reduction of oximes adjacent to double bonds 
to amines. These reactions were abandoned as not promising. 
2.2 Experimental Part 
The adopted experimental procedure followed the course of APPEL reaction and Alkenes 
hydrogenation (Al Soom & Thiemann, 2016). 
2.2.1 Chemical and Solvents 
 CH3CN (190 far UV, super purity, (Romil Chemicals) and CH2Cl2 (Aldrich) were 
used as solvents for the UV-VIS spectroscopic measurements as received.  
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 NaBH4 (Fisher Scientific), ammonium cerium nitrate (CAN, Fisher Scientific), 
ethyl bromo-acetate (Ventron), bromo-tri-chloromethane (BrCCl3, Aldrich), tetra-
chloro-carbon (CCl4, Riedel-de-Haёn), 2,5-dimethoxy-benzaldehyde (25d), 3-
hydroxy-4-methoxy-benzaldehyde (24a) (Aldrich), tri-phenyl-phosphine (PPh3, 
Aldrich), Pd/C (Aldrich, 5 wt%, 205680) were acquired commercially, and were 
used as received. 
2.2.2 Instrumentation 
 Melting points were measured on Stuart SMP 10 melting point apparatus, and 
were uncorrected.  
 Infrared spectra were measured with a Thermo/Nicolet Nexus 470 FT-IR ESP 
Spectrometer.  
 1H and 13C NMR spectra were recorded with a Varian 400 NMR (1H at 395.7 
MHz, 13C at 100.5 MHz) and a Varian 200 MHz NMR spectrometer (1H at 200.0 
MHz, 13C at 50.3 MHz). The chemical shifts are relative to TMS (solvent CDCl3, 
unless otherwise noted).  
 Mass spectra were measured with a JMS-01-SG-2 spectrometer.  
 CHN-analysis was performed on a LECO TruSpec Micro instrument.  
 Column chromatography was carried out on silica gel (60 A, 230 – 400 mesh, 
Sigma-Aldrich). 




Safety notice: Regarding caution for hydrogenations using NaBH4, Pd/C, AcOH in 
toluene or benzene. In the presence of dry palladium on carbon, hydrogen enflames upon 
contact with air. Therefore, it is advisable to purge the reaction flasks with an inert gas 
before use in the described hydrogenation. Also, where filtrating the reaction mixture 
directly, especially when using a paper filter, it must be noted that the filter cake upon 
drying can enflame due to the fact that unreacted sodium borohydride slowly hydrolyses 
with air moisture, thereby releasing hydrogen. Therefore, after diligent washing with 
chloroform, the filter and filter cake should be immersed fully in water for sometimes.   
2.2.3 Preparation 
Ethoxycarbonylmethylidenetriphenylphosphorane (23) 
To a solution of triphenyl-phosphine (20, PPh3, 12.3 g, 46.8 mmol) 
in CHCl3 (25 mL) was added ethyl bromoacetate (21, 7.77 g, 46.8 
mmol, careful: lachrymator!). The solution heated up during the addition. The reaction 
mixture was stirred at RT for 14 hr. Then, it was poured into ether (300 mL). The 
precipitate formed was allowed to settle for 3 hr. This is mainly 
ethoxycarbonylmethyltriphenylphosphonium bromide (22). The ethereal supernatant 
was decanted thereafter and aq. Na2CO3 (10 g Na2CO3 in 100 mL H2O) was added, 
followed by CH2Cl2 (35 mL). The reaction mixture was stirred at RT for 45 min. 
Thereafter, the mixture was extracted with CH2Cl2 (3 X 35 mL). The organic phase was 
dried over anhydrous MgSO4 and concentrated in vacuo to leave an oily residue from, 
which ethoxycarbonylmethylidenetriphenylphosphorane (23) crystallized upon seeding 
13 
 
to give compound 23 as a colourless solid (14.1 g, 87%). νmax (KBr/cm
-1) 3055, 2975, 
2900, 1605, 1483, 1437, 1371, 1330, 1121, 1062, 892, 755, 695, 545, 507. 
3,4-Diethoxybenzaldehyde (25a)  
To finely ground KOH (560 mg, 10 mmol) in DMSO (15 mL) is added 
3,4-dihydroxybenzaldehyde (protocathecuic acid, compound 24a, 700 
mg, 5.07 mmol). The mixture was stirred at RT for 15 min. Then, ethyl iodide (6.0 g, 38.5 
mmol) was added dropwise. The reaction mixture was stirred at RT for 36 hr. Then, water 
(35 mL) was added, and the mixture was extracted with CHCl3 (3 X 35 mL). The organic 
phase was dried over anhydrous MgSO4 and concentrated in vacuo. The residue was 
subjected to column chromatography on silica gel (CHCl3-hexane 2:1) to give compound 
25a (640 mg, 76%) slowly solidifying, colorless oil; δH (400 MHz, CDCl3) 1.48 (6H, t, 
3J 
= 6.8 Hz, 2 CH3), 4.16 (2H, q, 
3J = 6.8 Hz, OCH2), 4.17 (2H, q, 
3J = 6.8 Hz, OCH2), 6.95 
(1H, d, 3J = 8.0 Hz), 7.39 (1H, s), 7.40 (1H, d, 3J = 8.0 Hz), 9.82 (1H, s, CHO);  δC (100.5 
MHz, CDCl3) 14.5 (CH3), 14.6 (CH3), 64.5 (OCH2), 64.6 (OCH2), 110.6 (CH), 111.5 
(CH), 126.6 (CH), 129.7 (Cquat), 149.0 (Cquat), 154.2 (Cquat), 191.0 (CHO). 
3-Benzyloxy-4-methoxybenzaldehyde (25b).  
A suspension of finely ground KOH (1.12 g, 20 mmol) in DMSO (20 
mL) was stirred at RT for 15 min., and thereafter 3-hydroxy-4-
methoxybenzaldehyde (24b, 2.00 g, 13.1 mmol) was added, and the 
resulting mixture was stirred for 35 min. Then, benzyl chloride (3.30 g, 26.4 mmol) was 
added drop-wise, and the mixture was stirred for 14 hr at RT. Then, it was given into 
water (40 mL) and extracted with CHCl3 (3 X 35 mL). The organic phase was dried over 
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anhydrous MgSO4 and concentrated in vacuo. The residue was subjected to column 
chromatography on silica gel (hexane/CH2Cl2 1:3) to give compound 25b (3.1 g, 97.5%) 
as a pale yellow solid, MP. 61 oC (Lit. 63-65 oC [Schrittwieser et al. 2011]); vmax (neat/cm
-
1) 1684, 1585, 1434, 1267, 1133, 1017; δH (400 MHz, CDCl3) 3.95 (3H, s, OCH3), 5.18 
(2H, s, OCH2), 6.98 (1H, d, 
3J = 8.0 Hz), 7.31 – 7.44 (7H, m), 9.80 (1H, s, CHO); δC (67.8 
MHz, CDCl3) 56.2 (OCH3), 70.8 (OCH2), 110.7 (CH), 111.2 (Cquat), 126.9 (CH), 127.5 
(2C, CH), 128.0 (Cquat), 128.1 (CH), 128.7 (2C, CH), 129.9 (Cquat), 136.2 (CH), 148.6 
(Cquat), 155.0 (Cquat), 190.0 (CHO). 
(E)-3,4-Diethoxycinnamic acid (27a).  
A mixture of 3,4-diethoxybenzaldehyde (25a, 970 mg, 5.0 mmol) 
and ethoxycarbonylmethylidenetriphenylphosphorane (2.09 g, 
6.0 mmol) in aq. NaOH (2.0 g NaOH in 20 mL H2O) was stirred at 70 
oC for 2 hr and at 
90 oC for 12 hr. The cooled solution was acidified with half-conc. aq. HCl. The formed 
suspension was let to stand for 3hr. Thereafter, the precipitate was filtered off and the 
filter cake was washed diligently with water (3 X 25 mL). The solid was air-dried to give 
compound 27a (1.16 g, 4.91 mmol, 98%) as a colorless solid; MP. 154 – 156oC; Vmax 
(KBr/cm-1) 3500 – 2850 (bs, OH), 1696, 1629, 1596, 1517, 1430, 1398, 1330, 1040, 978, 
802, 594, 529; δH (400 MHz, CDCl3) 1.46 (6H, t, 
3J = 6.8 Hz, 2 CH3), 4.12 (2H, q, 
3J = 
6.8 Hz, OCH2), 4.13 (2H, q, 
3J = 6.8 Hz, OCH2), 6.28 (1H, d, 
3J = 16.0 Hz), 6.85 (1H, d, 
3J = 8.0 Hz), 7.07 (1H, s), 7.08 (1H, d, 3J = 8.0 Hz), 7.70 (1H, d, 3J = 16.0 Hz); δC (100.5 
MHz, CDCl3) 14.6 (CH3), 14.7 (CH3), 64.5 (OCH2), 64.6 (OCH2), 111.9 (CH), 112.6 
(CH), 114.6 (CH), 123.1 (CH), 126.9 (Cquat), 147.1 (CH), 148.8 (Cquat), 151.3 (Cquat), 




(E)-3,4-Dimethoxycinnamic acid (27c).  
Prepared analogous to 27a: (97%) as a colorless solid; [Lit. 181-
183 °C Aldrich Catalogue]; vmax (KBr/cm
-1) 3300 – 2500 (bs, OH), 
1677, 1624, 1596, 1517, 1463, 1426, 1340, 1250, 1140, 1025, 975, 840, 579, 536; δH (400 
MHz, DMSO-d6) 3.78 (3H, s, OCH3), 3.80 (3H, s, OCH3), 6.41 (1H, d, 
3J = 16.0 Hz), 
7.50 (1H, d, 3J = 16.0 Hz), 12.19 (1H, bs, OH); δC (100.5 MHz, DMSO-d
6) 56.0, 56.1, 
110.7, 112.0, 117.2, 123.1, 127.5, 144.6, 149.4, 151.2, 168.3.  
Ethyl (E)-3-benzyloxy-4-methoxycinnamate (28b).  
A mixture of 3-benzyloxy-4-methoxybenzaldehyde (25b, 2.42g, 10 
mmol) and ethoxycarbonylmethylidenetriphenyl phosphorane (23, 
5.57 g, 16 mmol) in CHCl3 (10 mL) was stirred for 2 hr at 80 oC. Direct column 
chromatography on silica gel (CH2Cl2) gave compound 28b (3.10 g, 99%) as a colorless 
solid, MP. 91 oC; vmax (KBr/cm
-1) 2932, 1705, 1635, 1512, 1265, 1177, 1136, 1011, 751, 
699, 607, 541; δH (400 MHz, CDCl3) 1.31 (3H, t, 
3J = 7.2 Hz, CH3), 3.90 (3H, s, OCH3), 
4.23 (2H, q, 3J = 7.2 Hz, OCH2), 5.15 (2H, s, OCH2), 6.22 (1H, d, 
3J = 16.0 Hz), 6.87 
(1H, d, 3J = 8.8 Hz), 7.07 (1H, d, 4J = 2.0 Hz), 7.10 (1H, dd, 3J = 8.8 Hz, 4J = 2.0 Hz), 
7.28 – 7.47 (5H, m), 7.56 (1H, d, 3J = 16.0 Hz); δC (67.8 MHz, CDCl3) 14.4 (CH3), 56.0 
(OCH3), 60.4 (OCH2), 71.0 (OCH2), 111.4 (CH), 112.4 (CH), 115.9 (CH), 122.9 (CH), 
127.3 (2C, CH), 127.6 (CH), 128.6 (2C, CH), 136.6 (Cquat), 144.5 (CH), 148.2 (Cquat), 
156.7 (Cquat), 167.3 (Cquat, CO). 
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N-Octyl 3-(1,4-dimethoxyphen-2-yl) propionamide (43g)  
As a colorless solid, MP. 63 - 64 oC; vmax (KBr/cm
-1) 3325 (NH), 
2999, 2959, 2923, 2852, 1641, 1533, 1504, 1469, 1220, 1047, 852, 
807, 696; δH (400 MHz, CDCl3) 0.87 (3H, t, 
3J = 6.8 Hz, CH3), 1.20 – 1.29 (10H, m), 1.37 
– 1.44 (2H, m), 2.45 (2H, t, 3J = 7.2 Hz), 2.90 (2H, t, 3J = 7.2 Hz), 3.18 (2H, bq, 3J = 6.4 
Hz, NCH2), 3.73 (3H, s, OCH3), 3.76 (3H, s, OCH3), 6.69 (1H, dd, 
3J = 8.8 Hz, 4J = 3.2 
Hz), 6.73 (1H, d, 4J = 3.2 Hz), 6.76 (1H, d, 3J = 8.8 Hz); δC (67.8 MHz, CDCl3) 14.1 
(CH3), 22.6 (CH2), 26.7 (CH2), 26.9 (CH2), 29.2 (CH2), 29.2(5) (CH2), 29.6 (CH2), 31.8 
(CH2), 36.9 (CH2), 39.6 (CH2), 55.6 (OCH3), 55.8 (OCH3), 111.3 (CH), 111.7 (CH), 116.2 
(CH), 130.2 (Cquat), 151.4 (Cquat), 153.5 (Cquat), 172.4 (Cquat, CO). 
N-Piperidinyl 3-(1,4-dimethoxyphen-2-yl) propionamide (43h) 
As a colorless oil; vmax (KBr/cm
-1) 2997, 2938, 2856, 2834, 1635, 
1500, 1443, 1223, 1049, 1028, 752; δH (400 MHz, CDCl3) 1.59 (1H, 
m), 1.49 (4H, bs), 2.57 (2H, m), 2.89 (2H, m), 3.35 (2H, bs), 3.54 (2H, bs), 3.74 (3H, s, 
OCH3), 3.77 (3H, s, OCH3), 6.69 (1H, dd, 
3J = 8.8 Hz, 4J = 2.8 Hz), 6.75 (1H, d, 4J = 2.8 
Hz), 6.76 (1H, d, 3J = 8.8 Hz); δC (67.8 MHz, CDCl3) 24.5 (CH2), 25.6 (bs, CH2), 26.4 
(bs, CH2), 27.1 (CH2), 33.7 (CH2), 42.7 (bs, CH2), 46.6 (bs, CH2), 55.7 (OCH3), 55.8 
(OCH3), 111.1 (CH), 111.4 (CH), 116.3 (CH), 130.8, 151.7 (Cquat), 153.5 (Cquat), 171.0 
(Cquat, CO). 
N-Pyrrolidinyl 3-(1,4-dimethoxyphen-2-yl) propionamide (43i) 
 As a colorless oil; (KBr/cm-1) vmax  2950, 2874, 2834, 1635 (CONR2), 
1501, 1442, 1224, 1047, 733; δH (400 MHz, CDCl3) 1.79 – 1.89 (4H, 
m), 2.51 (2H, t, 3J = 8.4 Hz), 2.92 (2H, t, 3J = 8.4 Hz), 3.31 (2H, dd, 3J = 6.8 Hz, 3J = 6.8 
17 
 
Hz, 3J = 6.8 Hz), 3.45 (2H, dd, 3J = 6.8 Hz, 3J = 6.8 Hz), 3.73 (3H, s, OCH3), 3.76 (3H, s, 
OCH3), 6.69 (1H, dd, 
3J = 8.8 Hz, 4J = 3.2 Hz), 6.75 (1H, d, 3J = 8.8 Hz), 6.76 (1H, d, 4J 
= 3.2 Hz); δC (100.5 MHz, CDCl3) 24.4 (CH2), 26.1 (CH2), 26.5 (CH2), 35.1 (CH2), 45.6 
(CH2), 46.5 (CH2), 55.7 (OCH3), 55.9 (OCH3), 111.2 (CH), 111.5 (CH), 116.3 (CH), 
131.0 (Cquat), 151.7 (Cquat), 153.5 (Cquat), 171.3 (Cquat, CO). 
N-Benzyl 3-(1,4-dimethoxyphen-2-yl) propionamide (43j)  
As a colorless solid;(KBr/cm-1) vmax 3600 - 3150, 3412, 3284, 
2943, 2910, 2833, 1642, 1534, 1453, 1417, 1222, 1944, 807, 744, 
698; δH (400 MHz, CDCl3) 2.45 (2H, t, 
3J = 7.6 Hz), 2.88 (2H, t, 3J = 7.6 Hz), 3.64 (3H, 
s, OCH3), 3.66 (3H, s, OCH3), 4.33 (2H, d, 
3J = 5.6 Hz), 5.78 (1H, bs, NH), 6.63 – 6.69 
(3H, m), 7.08 – 7.11 (2H, m), 7.18 – 7.25 (3H, m); δC (100.5 MHz, CDCl3) 24.6 (CH2), 
36.8 (CH2), 43.6 (NCH2), 55.7 (OCH3), 55.8 (OCH3), 111.3 (CH), 111.8 (CH), 116.2 
(CH), 127.4 (CH), 127.7 (2C, CH), 128.6 (2C, CH), 130.0 (Cquat), 138.3 (Cquat), 151.4 
(Cquat), 153.5 (Cquat), 172.3 (Cquat, CO).  
N, N-Bis(2-ethylhexyl) 3-(1,4-dimethoxyphen-2-yl) propionamide (43k)  
As a colorless oil; vmax (neat/cm
-1) 2958, 2930, 2872, 1643, 1501, 
1464, 1224, 1052, 754; δH (400 MHz, CDCl3) 0.83 – 0.89 (16H, m), 
1.19 – 1.29 (20H, m), 1.50 – 1.65 (2H, m), 2.57 – 2.88 (2H, m), 2.90 
(2H, d, 3J = 9.0 Hz), 3.11 (2H, d, 3J = 7.6 Hz), 3.24 (2H, ddd, 2J = 7.6 Hz, 3J = 12.0 Hz, 
4J = 2.0 Hz), 3.73 (3H, s, OCH3), 3.76 (3H, s, OCH3), 6.69 (1H, dd, 
3J = 9.2 Hz, 4J = 2.8 
Hz), 6.75 (1H, d, 3J = 9.2 Hz), 6.76 (1H, d, 4J = 2.8 Hz); δC (67.8 MHz, CDCl3, DEPT) 
10.6 (CH3), 10.9 (CH3), 14.0(5) (CH3), 14.1 (CH3), 23.0 (CH2), 23.1 (CH2), 23.7(5) (CH2), 
18 
 
23.8 (CH2), 27.5 (CH2), 28.7 (CH2), 28.7 (5) (CH2), 30.4 (CH2), 30.5 (CH2), 33.7 (CH2), 
36.9 (CH), 38.4 (CH), 48.7 (NCH2), 51.4 (NCH2), 55.6 (OCH3), 55.7 (OCH3), 110.9 (CH), 
111.5 (CH), 116.4 (CH), 130.8 (Cquat), 151.7 (Cquat), 153.4 (Cquat), 173.3 (Cquat, CO). 
N, N-Di(n-propyl) 3-(1,4-dimethoxyphen-2-yl) propionamide (43L)  
As a colorless oil; vmax neat/cm
-1) 2965, 1638, 1502, 1466, 1224, 1051, 802; δH (400 MHz, 
CDCl3) 0.86 (6H, t, 
3J = 7.2 Hz, 2 CH3), 1.48 – 1.54 (4H, m), 2.55 
(2H, t, 3J = 8.0 Hz), 2.91 (2H, t, 3J = 8.0 Hz), 3.14 (2H, t, 3J = 7.6 Hz), 
3.25 (2H, t, 3J = 7.6 Hz), 3.74 (3H, s, OCH3), 3.77 (3H, s, OCH3), 6.69 (1H, dd, 
3J = 6.8 
Hz, 4J = 2.8 Hz), 6.75 (1H, d, 3J = 6.8 Hz), 6.77 (1H, d, 4J = 2.8 Hz); δC (67.8 MHz, 
CDCl3) 11.2 (CH3), 11.4 (CH3), 21.0 (CH2), 21.2 (CH2), 27.4 (CH2), 33.4 (CH2), 47.6 
(NCH2), 49.6 (NCH2), 55.6(5) (OCH3), 55.7 (OCH3), 111.0 (CH), 111.5 (CH), 116.4 
(CH), 130.8 (Cquat), 151.7 (Cquat), 153.4 (Cquat), 172.4 (Cquat, CO). 
3-(2,5-Dimethoxyphenyl) propionic acid (57b). 
Ethyl 3-(2,5-dimethoxyphenyl) propionate (27b, 3.2 g, 13.4 mmol) 
in a mixture of aq. NaOH (10 w%, 30 mL) and methanol (8 mL) was 
heated at reflux for 12h. Then, half. conc. aq. HCl is added to the 
cooled solution. Thereafter, the mixture is extracted with chloroform (3 X 15 mL). The 
organic phase is dried over anhydrous MgSO4 and concentrated in vacuo. The residue is 
filtered over a small column of silica gel (ether-CHCl3, 1:1, v/v) to give compound 27b 
(2.56 g, 89%) as colorless needles, MP. 66 – 67 oC [Lit. MP. 66 – 67 oC]; vmax (KBr/cm
-
1) 3500 – 2050 (bs, OH), 2955, 2835, 1699, 1504, 1449, 1430, 1307, 1281, 1182, 1127, 
927, 916, 865, 795, 717, 499; δH (400 MHz, CDCl3) 2.65 (2H, t, 
3J = 7.6 Hz), 2.91 (2H, 
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t, 3J = 7.6 Hz), 6.71 (1H, dd, 3J = 8.4 Hz, 4J = 3.2 Hz), 6.75 (1H, d, 4J = 3.2 Hz), 6.76 (1H, 
d, 3J = 8.4 Hz), δC (67.8 MHz, CDCl3) 26.0 (CH2), 33.9 (CH2), 55.6 (OCH3), 55.7 (OCH3), 
111.0, 111.6, 116.3, 129.6, 151.7 (Cquat), 153.3 (Cquat), 179.7 (Cquat, CO). 
N-Octylcarboxamidoethyl-p-benzoquinone (58a).  
To compound 43g (442 mg, 1.32 mmol) in acetonitrile (15 mL) was 
added dropwise and at RT and within 15 min. a solution of CAN (2.23 g, 8.14 mmol) in 
H2O (15 mL). The resulting mixture was stirred for an additional 5 min. at RT. Thereafter, 
water was added and the mixture was extracted with CH2Cl2 (3 X 15 mL). The combined 
organic phase was dried over anhydrous MgSO4 and concentrated in vacuo. The residue 
was subjected to chromatographic separation on silica gel (CH2Cl2/Et2O 8:2) to give 
compound 58a (206 mg, 51%) as a yellow solid, MP. 111-113oC vmax (KBr/cm
-1) 3331 
(vs, NH), 3052, 2954, 2924, 2851, 1655 (CO), 1537, 1427, 1311, 1131, 921, 837, 427; δH 
(400 MHz, CDCl3) 0.81 (3H, t, 
3J = 6.8 Hz, CH3), 1.19 – 1.22 (10H, m), 1.37 – 1.42 (2H, 
m), 2.34 (2H, t, 3J = 7.6 Hz), 2.71 (2H, dt, 3J = 7.6 Hz, 4J = 1.6 Hz), 3.16 (2H, dt, 3J = 7.2 
Hz, J = 7.2 Hz), 5.53 (1H, bs, NH), 6.55 – 6.56 (1H, m), 6.65 (1H, dd, 3J = 10.0 Hz, 4J= 
2.4 Hz), 6.70 (1H, d, 3J = 10.0 Hz); δC (67.8 MHz, CDCl3) 14.1 (CH3), 22.6 (CH2), 25.3 
(CH2), 26.9 (CH2), 29.1 (CH2), 29.2 (CH2), 29.6 (CH2), 31.8 (CH2), 34.3 (CH2), 39.7 
(CH2), 133.1 (CH), 136.4 (CH), 136.7 (CH), 147.8 (Cquat), 170.7 (Cquat, CONH), 187.4 
(Cquat, CO), 187.5 (Cquat, CO). 
N-Piperidinylcarboxamidoethyl-p-benzoquinone (58b).  
To compound 43h (450 mg, 1.64 mmol) in acetonitrile (15 mL) 
was added dropwise and at RT and within 15 min. a solution of 
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CAN (2.74 g, 10 mmol) in H2O (15 mL). The resulting mixture was stirred for an 
additional 5 min. at rt. Thereafter, water was added and the mixture was extracted with 
CH2Cl2 (3 X 15 mL). The combined organic phase was dried over anhydrous MgSO4 and 
concentrated in vacuo. The residue was subjected to chromatographic separation on silica 
gel (CHCl3/ Et2O/ hexane 1:1:1) to give compound 58b (169 mg, 37 [5] %) as a yellow-
orange solid, MP. 105-106 oC; vmax (KBr/cm
-1) 3049, 3017, 2918, 2848, 1656, 1598, 1455, 
1429, 1299, 1216, 1012, 915, 855, 834, 428; δH (400 MHz, CDCl3)1.51 (4H, bm), 1.58 – 
1.64 (2H, m), 2.53 (2H, t, 3J = 6.8 Hz), 2.73 (2H, t, 3J = 6.8 Hz, 4J = 1.2 Hz), 3.38 (1H, 
bs), 3.49 (1H, bs), 6.58 (1H, m), 6.67 (1H, d, 3J = 10 Hz, 4J = 1.2 Hz), 6.72 (1H, d, 3J = 
10 Hz); δC (67.8 MHz, CDCl3) 24.4 (2C, CH2), 25.2 (CH2), 25.5 (bs, CH2), 26.4 (bs, CH2), 
31.3 (CH2), 42.8 (bs, CH2), 46.2 (bs, CH2), 133.1 (CH), 136.3 (CH), 136.8 (CH), 148.5 
(Cquat), 169.1 (Cquat, CON), 187.5 (Cquat, CO), 187.6 (Cquat, CO). 
N-Pyrrolidinylcarboxamidoethyl-p-benzoquinone (58c).  
Reacted according to the preparation of compound 58a: light brown 
solid; (KBr/cm-1) vmax 3054, 2953, 2874, 1660, 1442, 1328, 1295, 
1035, 989, 916, 753, 427; δH (400 MHz, CDCl3) 1.81 – 1.86 (2H, m), 1.90 – 1.96 (2H, 
m), 2.49 (2H, d, 3J = 7.2 Hz), 2.77 (2H, t, 3J = 7.2 Hz), 3.38 (2H, t, 3J = 6.4 Hz), 3.44 (2H, 
t, 3J = 7.2 Hz), 6.58 (1H, m), 6.67 (1H, d, 3J = 10 Hz, 4J = 1.2 Hz), 6.72 (1H, d, 3J = 10 
Hz); δC (100.5 MHz, CDCl3) 24.3 (CH2), 24,6 (CH2), 26.1 (CH2), 32.6 (CH2), 45.8 (CH2), 
46.5 (CH2), 133.1 (CH), 136.3 (CH), 136.8 (CH), 148.5 (Cquat), 169.5 (Cquat, CON), 187.5 
(Cquat, CO), 187.6 (Cquat, CO). 
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N-Benzyl carboxamidoethyl-p-benzoquinone (58d).   
Reacted analogous to the preparation of compound 58a: light 
brown solid; (KBr/cm-1) vmax 3299, 2927, 1670, 1660, 1530, 
1295, 1219, 1073, 930, 754, 697, 578; δC (100.5 MHz, CDCl3) 25.3 (CH2), 34.2 (CH2), 
43.7 (NCH2), 127.6 (CH), 127.8 (2C, CH), 128.8 (2C, CH), 132.2 (CH), 136.4 (CH), 
136.7 (CH), 137.9 (Cquat), 147.7 (Cquat), 170.7 (Cquat, CONH), 187.3 (Cquat, CO), 187.4 
(Cquat, CO). 
N, N-Bis(2-ethylhexyl)carboxamidoethyl-p-benzoquinone (58e). 
To compound 43k (417 mg, 0.96 mmol) in CH3CN (11 mL) was 
added dropwise a solution of CAN (1.63 g, 5.94 mmol) in H2O (11 
mL). The resulting solution was stirred for 15 min. at RT. Then, water (25 mL) was added 
and the mixture was extracted with CH2Cl2 (3X25 mL). The organic phase was dried over 
MgSO4 and concentrated in vacuo. Column chromatography on silica gel (CH2Cl2-ether 
10:1) gave compound 58e (165 mg, 43%) as a yellow oil; Vmax (neat/cm
-1) 2931, 1658, 
1463, 1380, 1291, 1220, 1129, 1080, 903; δH (400 MHz, CDCl3) 0.81 – 0.87 (16H, m), 
1.13 – 1.24 (20H, m), 1.58 (2H, m), 2.55 (2H, t, 3J = 7.2 Hz), 2.76 (2H, dt, 3J = 7.2 Hz, 4J 
= 2.4 Hz), 3.11 (2H, d, 2J = 7.6 Hz), 3.23 (2H, ddd, 2J = 7.6 Hz, 3J = 12.0 Hz, 4J = 2.0 
Hz), 6.59 (1H, m), 6.68 (1H, dd, 3J = 10.0 Hz, 4J = 2.4 Hz), 6.73 (1H, d, 3J = 10.0 Hz); δC 
(67.8 MHz, CDCl3) 10.6 (CH3), 10.9 (CH3), 14.0 (CH3), 14.1 (CH3), 23.0 (CH2), 23.1 
(CH2), 23.7(5) (CH2), 23.8 (CH2), 25.5 (CH2), 28.6 (CH2), 28.7 (CH2), 30.4 (CH2), 30.5 
(CH2), 31.4 (CH2), 36.9 (CH), 38.3 (CH), 48.8 (NCH2), 51.3 (NCH2), 133.2 (CH), 136.3 
(CH), 136.7 (CH), 148.4 (Cquat), 171.3 (Cquat, CON), 187.5 (Cquat, CO), 187.6 (Cquat, CO). 
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2-Phenylethyl 1,4-dimethoxy-2-cinnamate (60)  
 As a yellow oil; vmax (neat/cm
-1) 1720, 1496, 1454, 1221, 
1164, 1046; δH (400 MHz, CDCl3) 3.01 (2H, t, 
3J = 6.8 
Hz), 3.78 (3H, s, OCH3), 3.83 (3H, s, OCH3), 4.41 (2H, t, 
3J = 6.8 Hz), 6.46 (1H, d, 3J = 
16.0 Hz), 6.84 (1H, d, 3J = 9.2 Hz), 6.90 (1H, dd, 3J = 9.2 Hz, 4J = 3.2 Hz), 7.03 (1H, d, 
4J = 3.2 Hz), 7.21 – 7.33 (5H, m), 7.96 (1H, d, 3J = 16.0 Hz); δC (67.8 MHz, CDCl3) 33.2 
(CH2), 55.8 (OCH3), 56.1 (OCH3), 64.9 (OCH2), 112.4 (CH), 113.2 (CH), 117.1 (CH), 
118.6 (CH), 123.9 (Cquat), 126.5 (CH), 128.5 (2C, CH), 129.0 (2C, CH), 137.9 (Cquat), 
140.0 (CH), 152.8 (Cquat), 153.4 (Cquat), 167.3 (Cquat, CO). 
2-Phenylethyl 1,4-dimethoxy-2-phenylpropionate (61)  
 As a colorless oil; vmax (neat/cm
-1) 1731, 1501, 1224, 1157, 
1048; δH (400 MHz, CDCl3) 2.54 (2H, t, 
3J = 7.6 Hz), 2.84 
(2H, t, 3J = 7.6 Hz), 2.87 (2H, t, 3J = 7.2 Hz), 3.69 (3H, s, OCH3), 3.72 (3H, s, OCH3), 
4.23 (2H, t, 3J = 7.2 Hz), 6.65(5) (1H, d, 3J = 8.4 Hz), 6.67 (1H, s), 6.71 (1H, d, 3J = 8.4 
Hz), 7.19 - 7.32 (5H, m); δC (67.8 MHz, CDCl3) 26.2 (CH2), 34.2 (CH2), 35.1 (CH2), 55.7 
(OCH3), 55.7(5) (OCH3), 64.9 (OCH2), 111.0 (CH), 111.4 (CH), 126.3 (CH), 126.5 (CH), 
128.5 (2C, CH), 128.9 (2C, CH), 130.0 (Cquat), 137.9 (Cquat), 151.7 (Cquat), 153.3 (Cquat), 
173.2 (Cquat, CO). 
Ethyl 3-(1,4-dimethoxyphen-2-yl) propionate (61-Et)  
As a colorless oil; (KBr/cm-1) vmax 2937, 2834, 1732, 1591, 
1502, 1464, 1372, 1224, 1123, 1049, 867, 803, 710; δH (400 
MHz, CDCl3) 1.23 (3H, t, 
3J = 7.2 Hz), 2.58 (2H, t, 3J = 8.0 




7.2 Hz), 6.69 (1H, dd, 3J = 8.8 Hz, 4J = 2.8 Hz), 6.73 (1H, d, 4J = 2.8 Hz), 6.75 (1H, d, 3J 
= 8.8 Hz); δC (100.5 MHz, CDCl3) 14.2 (CH3), 26.2 (CH2), 34.2 (CH2), 55.6 (OCH3), 55.7 
(OCH3), 60.3 (OCH2), 111.0 (CH), 111.4 (CH), 116.3 (CH), 130.0 (Cquat), 151.7 (Cquat), 
153.3 (Cquat), 173.3 (Cquat, CO). 
2-Phenylethoxycarbonylethyl-p-benzoquinone (62)  
As a dark orange solid; MP. 43 – 44 oC; vmax (KBr/cm
-1) 3060, 
2964, 1736, 1666, 1598, 1303, 1183, 1170, 1091, 701, 428; δH 
(400 MHz, CDCl3) 2.54 (2H, t, 
3J = 7.2 Hz), 2.69 – 2.73 (2H, m), 2.91 (2H, t, 3J = 7.2 
Hz), 4.29 (2H, t, 3J = 7.2 Hz), 6.52 (1H, m), 6.69 (1H, dd, 3J = 10.4 Hz, 4J = 2.4 Hz), 6.74 
(1H, d, 3J = 10.4 Hz), 7.17 – 7.31 (5H, m); δC (67.8 MHz, CDCl3) 24.5 (CH2), 31.9 (CH2), 
35.0 (CH2), 65.2 (OCH2), 126.6 (CH), 128.5 (2C, CH), 128.8 (2C, CH), 133.0 (CH), 136.6 
(CH), 136.7 (CH), 137.6 (Cquat), 147.4 (Cquat), 171.8 (Cquat, CO), 187.1 (Cquat, CO), 
187.4 (Cquat, CO). 
3-Hydroxy-4-methoxycinnamic acid (27e).  
A solution of ethyl 3-hydroxy-4-methoxycinnamate (28a, 
3.65 g, 16.4 mmol) in a mixture of aq. NaOH (5g NaOH in 50 
mL H2O) and CH3OH (10 mL) was stirred at 95 
oC for 14h. The cooled solution was 
acidified with half-conc. aq. HCl and extracted with CHCl3 (3 X 35 mL). The organic 
phase was dried over anhydrous MgSO4 and concentrated in vacuo to give compound 27e 
(2.83 g, 89%) as a colorless solid, MP. 235 oC [Lit. 230 – 232 oC (Prachayasittikul et al. 
2009)]; vmax (KBr/cm
-1) 3404 (bs, OH), 3200 – 2587 (bs, OH), 2943, 2846, 1671 (CO), 
1629, 1514, 1443, 1322, 1265, 1208, 1136, 1024, 947, 857, 817, 762, 572, 506; δH (400 
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MHz, CDCl3) 3.93 (3H, s, OCH3), 6.28 (1H, d, 
3J = 16.0 Hz), 6.85 (1H, d, 3J = 8.4 Hz), 
7.05 (1H, dd, 3J = 8.4 Hz, 4J = 2.4 Hz), 7.15 (1H, d, 4J = 2.4 Hz), 7.67 (1H, d, 3J = 16.0 
Hz). 
(E)-3-Benzyloxy-4-methoxycinnamic acid (27f).  
A suspension of 28b (2.65 g, 8.5 mmol) in a mixture of aq. 
NaOH (3.5 g NaOH in 35 mL H2O), EtOH (10 mL) and MeOH 
(10 mL) was stirred at 90 oC for 12h.The cooled solution was acidified with half-conc. aq. 
HCl. Thereafter, the mixture was extracted with CHCl3 (3 X 35 mL). The organic extract 
was dried over anhydrous MgSO4 and concentrated in vacuo to give compound 27f (1.75 
g, 73%) as a colorless solid; vmax (KBr/cm
-1) 3550 – 2450 (bs, OH), 2942, 1679, 1624, 
1593, 1519, 1266, 1138, 1012, 849, 807, 741, 699; δH (400 MHz, CDCl3) 3.91 (3H, s, 
OCH3), 5.17 (2H, s, OCH2), 6.22 (1H, d, 
3J = 16.0 Hz), 6.88 (1H, d, 3J = 8.0 Hz), 7.08 
(1H, d, 4J = 1.6 Hz), 7.13 (1H, dd, 3J = 8.0 Hz, 4J = 1.6 Hz), 7.29 – 7.48 (5H, m), 7.64 
(1H, d, 3J = 16.0 Hz); δC (67.8 MHz, CDCl3) 56.0 (OCH3), 71.0 (OCH2), 111.4 (CH), 
112.5 (CH), 114.7 (CH), 123.4 (CH), 127.3 (2C, CH), 128.1 (CH), 128.7 (2C, CH), 132.1 
(Cquat), 136.5 (Cquat), 146.8 (CH), 148.3 (Cquat), 152.1 (Cquat), 171.5 (Cquat, CO). 
A mixture of ethyl (E/Z)-3-hydroxy-4-methoxycinnamates (28a).  
A mixture of 3-hydroxy-4-methoxybenzaldehyde (24a, 1.39 g, 
9.14 mmol) and ethoxycarbonylmethylidenetriphenyl 
phosphorane (4.44 g, 12.8 mmol) was heated under stirring at 
135 oC for 90 min. The reaction took place in a melt of the mixture. After the reaction, 
the mixture was subjected directly to column chromatography on silica gel (CH2Cl2) to 
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give compound 28a (1.30 g, 64%) as a colorless oil; vmax (neat/cm
-1) 3550 – 3100 (bs, 
OH), 2980, 2842, 1699, 1633, 1583, 1513, 1441, 1266, 1179, 1132, 857, 806, 762, 724, 
695; δH (400 MHz, CDCl3) for E - 28a: 1.31 (3H, t, 
3J = 7.2 Hz, CH3), 3.90 (3H, s, OCH3), 
4.23 (2H, q, 3J = 7.2 Hz, OCH2), 6.27 (1H, d, 
3J = 16.0 Hz), 6.82 (1H, d, 3J = 8.8 Hz), 
7.01 (1H, dd, 3J = 8.8 Hz, 4J = 1.6 Hz), 7.12 (1H, d, 4J = 1.6 Hz), 7.57 (1H, d, 3J = 16.0 
Hz); for Z-28a: 1.26 (3H, t, 3J = 7.2 Hz, CH3), 3.89 (3H, s, OCH3), 4.18 (2H, q, 
3J = 7.2, 
OCH2), 5.81 (1H, d, 
3J = 13.2 Hz), 6.78 (1H, d, 3J = 13.2 Hz), 6.80 (1H, d, 3J = 8.8 Hz), 
7.21 (1H, dd, 3J = 8.8 Hz, 4J = 2.0 Hz), 7.30 (1H, d, 4J = 2.0 Hz); δC (67.8 MHz, CDCl3) 
for E-28a: 14.3 (CH3), 56.0 (OCH3), 60.4 (OCH2), 110.5 (CH), 112.8 (CH), 116.3 (CH), 
121.8 (CH), 128.0 (Cquat), 144.4 (CH), 145.8 (Cquat), 148.4 (Cquat), 167.3 (Cquat, CO). 
 
N-Benzyl (E)-3-benzyloxy-4-methoxycinnamamide (30h).  
 A solution of triphenylphosphine (PPh3, 980 mg, 3.74 mmol) 
and BrCCl3 (775 mg, 3.91 mmol) in CH3CN (10 mL) was stirred 
for 35 min. at RT, during which the solution became yellow-brown in color. Then, (E)-3-
benzyloxy-4-methoxycinnamic acid (860 mg, 3.03 mmol) was added as a solid to the 
solution. The solution was stirred at 75 oC for 45 min. Then, benzylamine (800 mg, 7.48 
mmol) was added drop-wise via syringe. The mixture was stirred for a further 14 hr at 75 
oC. The cooled solution was evaporated in vacuo to dryness. The residue was submitted 
to column chromatography on silica gel (ether/CHCl3 1:1) to give compound 30h (1.12 
g, quant) as a colorless solid, MP. 162 oC; vmax (KBr/cm
-1) 3412 (NH), 3312 (NH), 3064, 
2917, 2870, 1651, 1620, 1515, 1259, 1134, 1012, 974, 751, 697; δH (400 MHz, CDCl3) 
3.87 (3H, s, OCH3), 4.52 (2H, s, NCH2), 5.11 (2H, s, OCH2), 5.98 (1H, m, NH), 6.21 (1H, 
26 
 
d, 3J = 15.6 Hz), 6.84 (1H, d, 3J = 8.4 Hz), 7.01 (1H, d, 4J = 2.0 Hz), 7.06 (1H, dd, 3J = 
8.4 Hz, 4J = 2.0 Hz), 7.25 – 7.42 (10H, m), 7.53 (1H, d, 3J = 15.6 Hz); δC (67.8 MHz, 
CDCl3) 43.8 (NCH2), 56.0 (OCH3), 71.0 (OCH2), 111.5 (CH), 112.6 (CH), 118.2 (Cquat), 
122.3 (CH), 127.3 (2C, CH), 127.5 (CH), 127.6 (Cquat), 127.9 (2C, CH), 128.0 (2C, CH), 
128.6 (2C, CH), 128.7 (2C, CH), 136.7 (Cquat), 138.3 (Cquat), 141.2 (CH), 148.2 (CH), 
151.2 (Cquat), 166.0 (Cquat, CO). 
 
Ethyl 3-benzyloxy-4-methoxypropionate (41b). 
To compound 28b (3.20 g, 10.3 mmol) in toluene (20 mL) was 
added Pd/C (Aldrich 205680) (200 mg, 5 wt%) and AcOH (350 
mg). Thereafter, finely ground NaBH4 (500 mg) was added. After the mixture was stirred 
for 24h at RT, water (5 mL) was added slowly (drop-wise). Thereafter, half conc. HCl (3 
mL) was added. The mixture was poured into water (70 mL) and extracted with CHCl3 (3 
X 30 mL). The separated organic phase was dried over anhydrous MgSO4. The solvent 
was evaporated and the residue was subjected to column chromatography on silica gel 
(eluent CH2Cl2) to give ethyl 3-benzyloxy-4-methoxypropionate (41b, 1.80 g, 56%) as a 
colorless solid; vmax (KBr/cm-1) 1731, 1515; δH (400 MHz, CDCl3)1.22 (3H, t, 3J = 7.2 
Hz, CH3), 2.53 (2H, t, 
3J = 7.2 Hz), 2.81 (2H, t, 3J = 7.2 Hz), 3.85 (3H, s, OCH3), 4.09 
(2H, q, 3J = 7.2 Hz, OCH2), 5.11 (2H, s, OCH2), 6.74 (2H, d, 
3J = 8.8 Hz), 6.80 (2H, d, 3J 
= 8.8 Hz), 7.29 – 7.44 (5H, m); δC (67.8 MHz, CDCl3) 14.2 (CH3), 30.5 (CH2), 36.1 (CH2), 
56.1 (OCH3), 60.4 (OCH2), 71.0 (OCH2), 111.8 (CH), 114.4 (CH), 120.8 (CH), 127.3 (2C, 
CH), 127.8 (CH), 128.5 (3C, 2CH, Cquat), 133.1 (Cquat), 137.1 (Cquat), 148.0 (Cquat), 148.1 
(Cquat), 173.0 (Cquat, CO), and ethyl 3-hydroxy-4-methoxypropionate (960 mg) (eluent: 
27 
 
CH2Cl2-ether 10:1) as a colorless solid, MP. 72 
oC; vmax (KBr/cm
-1) 3380 (bs, OH), 2981, 
2960, 1727 (CO), 1588, 1517, 1300, 1270, 1179, 1147, 1126, 1007, 876, 804; δH (400 
MHz, CDCl3) 1.23 (3H, t, 
3J = 7.2 Hz, CH3), 2.56 (2H, t, 
3J = 8.0 Hz), 2.84 (2H, t, 3J = 
8.0 Hz), 4.11 (2H, q, 3J = 7.2 Hz, OCH2), 5.55 (1H, bs, OH), 6.65 (1H, dd, 
3J = 8.0 Hz, 4J 
= 2.0 Hz), 6.75 (1H, d, 3J = 8.0 Hz), 6.76 (1H, d, 4J = 2.0 Hz); δC (67.8 MHz, CDCl3) 14.2 
(CH3), 30.4 (CH2), 36.1 (CH2), 56.0 (OCH3), 60.4 (OCH2), 110.6 (CH), 114.5 (CH), 119.6 
(CH), 133.9 (Cquat), 145.0 (Cquat), 145.5 (Cquat), 173.0 (Cquat, CO). The reaction was carried 
out with 500 mg (1.60 mmol) starting material, 100 mg Pd/C (5 wt%), 255 mg AcOH, 
and 310 mg NaBH4 in toluene (10 mL) to give the product in 87% yield. 
Ethyl 3-hydroxy-4-methoxypropionate (41e).   
To compound 28a (960 mg, 4.32 mmol) in a solvent mixture 
of toluene (10 mL) and THF (5 mL) was added Pd/C (Aldrich 
205680) (150 mg, 5 wt%) and AcOH (560 mg). Thereafter, finely ground NaBH4 (680 
mg) was added.  After the mixture was stirred for 24h at RT, water (5 mL) was added 
slowly (dropwise). Thereafter, half conc. HCl (3 mL) was added. The mixture was poured 
into water (70 mL) and extracted with CHCl3 (3 X 30 mL). The separated organic phase 
was dried over anhydrous MgSO4. The solvent was evaporated and the residue was 
subjected to column chromatography on silica gel (eluent CH2Cl2/Et2O 10:1) to give ethyl 
3-hydroxy-4-methoxypropionate (960 mg, quant.). 
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N-Octyl 3-benzyloxy-4-methoxypropionamide (43d).   
A solution of triphenylphosphine (PPh3, 1.06 g, 4.05 mmol) 
and bromotrichloromethane (BrCCl3, 808 mg, 4.08 mmol) in 
dry CH2Cl2 (15 mL) was stirred at RT for 35 min., during 
which time the solution turned orange-brownish. Thereafter, 3-benzyloxy-4-methoxy 
phenylpropionic acid (57a, 1.0 g) was added (as a solid), and the mixture was stirred at 
reflux for 40 min. Then, n-octylamine (905 mg, 7.00 mmol) was added via syringe, and 
the resulting mixture was stirred at reflux for 14h. Then, the cooled solution was subjected 
to column chromatography on a silica gel (CH2Cl2/ether 40/3) to give compound 43d 
(1.09 g, 62%) as a colourless solid, MP. 116- 188 oC; vmax (KBr/cm
-1) 3328 (s), 3038, 
2953, 2929, 2850, 1642 (CO), 1536, 1516, 1255, 1136, 1017, 749, 700; δH (400 MHz, 
CDCl3) 0.86 (3H, t, 
3J = 6.8 Hz, CH3), 1.34-1.37 (2H, m), 1.23-1.28 (10H, m), 2.37 (2H, 
t, 3J = 7.6 Hz), 2.84 (2H, t, 3J = 7.6 Hz), 3.10 – 3.15 (2H, m, NCH2), 3.83 (3H, s, OCH3), 
5.12 (2H, s, OCH2), 5.38 (1H, bs, NH),6.73 (1H, d, 
4J = 2.0 Hz), 6.73(5) (1H, dd, 3J = 8.0 
Hz, 4J = 2.0 Hz), 6.78 (1H, d, 3J = 8.0 Hz), 7.28 – 7.44 (5H, m); δC (67.8 MHz, CDCl3) 
14.1 (CH3), 22.6 (CH2), 26.8 (CH2), 29.2 (CH2), 29.2(5) (CH2), 29.5 (CH2), 31.4 (CH2), 
31.8 (CH2), 38.6 (CH2), 39.6 (CH2), 56.0 (OCH3), 70.9 (OCH2), 111.8 (CH), 114.3 (CH), 
120.9 (CH), 127.4 (2C, CH), 127.8 (CH), 128.5 (2C, CH), 133.2 (Cquat), 137.2 (Cquat), 
148.0 (Cquat), 148.1 (Cquat), 172.3 (Cquat, CO). 
N-Benzyl 2,5-dimethoxycinnamamide.  
A mixture of PPh3 (720 mg, 2.75 mmol) and CCl4 (465 
mg, 3.03 mmol) in CH2Cl2 (10 mL) was stirred at 45 
oC for 40 min. Thereafter, 2,5-
dimethoxycinnamic acid (500 mg, 2.40 mmol, solid) was added to the mixture, and the 
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ensuing reaction mixture was stirred at 75 oC for 45 min. Then, benzylamine (515 mg, 
4.81 mmol) was added dropwise, and the mixture was stirred additional 14h. The cooled 
mixture was subjected directly to column chromatography on silica gel (CH2Cl2, then 
CH2Cl2-ether 3:1) to give N-benzyl 2,5-dimethoxycinnamide (610 mg) as a colourless 
solid; MP. 104 oC; vmax (KBr/cm
-1) 3288 (s, NH), 3076, 2989, 2923, 2831, 1652, 1615, 
1556, 1496, 1214, 1042, 849, 711, 700; δH (400 MHz, CDCl3) 3.76 (3H, s, OCH3), 3.81 
(3H, s, OCH3), 4.57 (2H, d, 
3J = 6.0 Hz), 5.87 (1H, bs, NH), 6.52 (1H, d, 3J = 15.6 Hz), 
6.82 (1H, d, 3J = 9.2 Hz), 6.86 (1H, dd, 3J = 9.2 Hz, 4J = 2.4 Hz), 6.99 (1H, d, 4J = 2.4 
Hz), 7.24 – 7.34 (5H, m), 7.85 (1H, d, 3J = 15.6 Hz); δC (67.8 MHz, CDCl3) 43.8 (NCH2), 
55.7 (OCH3), 56.0 (OCH3), 112.3 (CH), 113.9 (CH), 116.1 (CH), 121.6 (CH), 124.3 
(Cquat), 127.6 (CH), 128.0 (2C, CH), 128.7 (2C, CH), 136.7 (CH), 138.3 (Cquat), 152.7 
(Cquat), 153.4 (Cquat), 166.2 (Cquat, NCO). 
N-Piperidinyl 3-hydroxy-4-methoxypropionamide (43o).  
A mixture of N-piperidinyl 3-benzyloxy-4-methoxy-
propionamide (540 mg, 1.53 mmol), Pd/C (100 mg, Aldrich 
205680, 5 wt%) in toluene (10 mL) and AcOH (270 mg) was 
added finely ground NaBH4 (300 mg, 7.5 mmol). The resulting reaction mixture was 
stirred at RT for 24 h. Thereafter, AcOH (270 mg) was added. After 36 hr, further NaBH4 
(250 mg) and AcOH (300 mg) were added. After 48h, the reaction was stopped by adding 
dropwise H2O (5 mL), thereafter half conc. aq. HCl (3 mL). The mixture was taken up 
with H2O (25 mL). The mixture was extracted with CH2Cl2 (3 X 25 mL). The organic 
phase was dried over anhydrous MgSO4 and concentrated in vacuo to dryness. Column 
chromatography of the residue on silica gel (ether/CH2Cl2 1:2) gave compound 43o (320 
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mg, 87%) as a slowly crystallizing oil; vmax (neat/cm
-1) 2937, 2855, 1618, 1509, 1442, 
1271, 1130, 1028; δH (400 MHz, CDCl3) 1.46 – 1.51 (4H, m), 1.57 – 1.61 (2H, m), 2.58 
– 2.65 (2H, m), 2.83 – 2.89 (2H, m), 3.49 (bs, 2H), 3.85 (3H, s, OCH3), 6.68 – 6.81 (3H, 
m); δC (67.8 MHz, CDCl3) 24.4, 26.0 (vbs), 31.1, 34.9, 43.0 (vbs), 46.2 (vbs), 56.0, 110.7, 
114.5, 119.8, 134.3, 144.9(5), 145.5, 170.9 (Cquat, NCO). 
N-Octyl 3-hydroxy-4-methoxypropionamide (43n).  
 To a mixture of N-octyl 3-benzyloxy-4-methoxy propion amide 
(1.06 g, 2.67 mmol), Pd/C (210 mg, Aldrich 205680, 5 wt%) in 
toluene (10 mL) and THF (5 mL) and AcOH (560 mg) was added finely ground NaBH4 
(400 mg, 10 mmol). The resulting reaction mixture was stirred atRTfor 24 h. Thereafter, 
AcOH (300 mg) was added; a further amount of AcOH (250 mg) was added after 48h. 
After 72 hr., further NaBH4 (250 mg) and AcOH (300 mg) were added. Further AcOH 
(300 mg) was added to the mixture after 85 hr. After 96 hr., the reaction was stopped by 
adding dropwise H2O (5 mL), thereafter half conc. aq. HCl (3 mL). The mixture was taken 
up with H2O (25 mL) and extracted with ethyl acetate (25 mL). The organic phase was 
dried over anhydrous MgSO4 and concentrated in vacuo. The residue was subjected to 
column chromatography on silica gel (first CH2Cl2 to remove residual toluene, then 
CH2Cl2/ether 3:1) to give N-octyl 3-hydroxy-4-methoxypropionamide (43n, 600 mg, 
73%) as a colorless solid, MP. 125 oC; vmax (KBr/cm
-1) 3513, 3302, 2957, 2924, 2850, 
1640, 1537, 1518, 1283, 1223, 1023, 863, 807; δH (400 MHz, CDCl3) 0.86 (3H, t, 
3J = 6.8 
Hz, CH3), 1.23 – 1.29 (10H, m), 1.36 – 1.43 (2H, m), 2.42 (2H, t, 
3J = 7.6 Hz), 2.85 (2H, 




8.0 Hz, 4J = 2.0 Hz), 6.75 (1H, d, 3J = 8.0 Hz), 6.76 (1H, d, 4J = 2.0 Hz); δC (67.8 MHz, 
CDCl3) 14.1 (CH3), 22.6 (CH2), 26.8 (CH2), 29.2 (CH2), 29. 
.2(5) (CH2), 29.5 (CH2), 31.2 (CH2), 31.8 (CH2), 38.6 (CH2), 39.6 (CH2), 55.9 (OCH3), 
110.6 (CH), 114.4 (CH), 119.8 (CH), 134.0 (Cquat), 145.01 (Cquat), 145.5 (Cquat), 172.3 
(Cquat, CO). 
N, N-Bis(n-propyl) 3-hydroxy-4-methoxypropionamide (43e). 
Reacted analogous to 43n. (67%) as a pale pink oil; vmax (neat/cm
-1) 
3268 (bs, OH), 2963, 2875, 1622, 1513, 1438, 1375, 1273, 1129, 1029, 
900, 869, 820, 760, 731; δH (400 MHz, CDCl3) 0.86 (6H, t, 
3J = 7.2 Hz, 2 CH3), 1.48 – 
1.56 (4H, m, 2 CH2), 2.58 (2H, t, 
3J = 8.0 Hz), 2.88 (2H, t, 3J = 8.0 Hz), 3.10 (2H, bt, 3J 
= 8.0 Hz, NCH2), 3.26 (2H, bt, 
3J = 7.6 Hz, NCH2), 6.69 (1H, dd, 
3J= 8.4 Hz, 4J = 2.0 
Hz), 6.75 (1H, d, 3J = 8.4 Hz), 6.78 (1H, d, 4J = 2.0 Hz); δC (67.8 MHz, CDCl3) 11.2 
(CH3), 11.4 (CH3), 20.9 (CH2), 22.1 (CH2), 31.2 (CH2), 35.1 (CH2), 47.9 (NCH2), 49.2 
(NCH2), 56.0 (OCH3), 110.7 (CH), 114.5 (CH), 119.8 (CH), 134.6 (Cquat), 144.9 (Cquat), 
145.5 (Cquat), 172.2 (Cquat, CO). 
3-[3-Benzyloxy-4-methoxyphenyl]propionic acid (57a).  
A mixture of 3-[3-benzyloxy-4-methoxy-phenyl]-propionate 
(41b, 1.8 g, 5.7 mmol) in aq. NaOH (2.4 g NaOH in 24 mL H2O) 
and CH3OH (7 mL) was stirred at 90 
oC for 14h. The cooled solution was acidified with 
half-conc. aq. HCl. The mixture was extracted with CHCl3 (3 X 25 mL). The organic 
phase was dried over anhydrous MgSO4 and concentrated in vacuo to give 57a (1.47 g, 
90%) as a colorless solid, MP. 125 – 127 oC; vmax (KBr/cm
-1) 1700, 1521, 1241, 1146, 
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1013, 810; δH (400 MHz, CDCl3) 3.85 (3H, s, OCH3), 5.12 (OCH2), 6.73 – 6.76 (2H, m), 
6.81 (1H, d, 3J = 8.4 Hz), 7.27 – 7.37 (4H, m), 7.43 (2H, d, 3J = 8.8 Hz); δC (67.8 MHz, 
CDCl3) 30.1 (CH2), 35.7 (CH2), 56.0 (OCH3), 71.0 (OCH2), 111.9 (CH), 114.4 (CH), 
120.8 (CH), 127.4 (2C, CH), 127.8 (CH), 128.5 (2C, CH), 132.7 (Cquat), 137.1 (Cquat), 
148.0 (Cquat), 148.2 (Cquat), 178.7 (Cquat, CO).  
3-Hydroxy-4-methoxyphenylpropionic acid (57c).  
Variation A: A solution of ethyl 3-hydroxy-4-methoxy-
phenylpropionate (41e, 960 mg, 4.29 mmol) in a mixture of aq. 
NaOH (10 w% NaOH, 30 mL) and MeOH (5 mL) was stirred at 110 oC for 8 hr. To the 
cooled solution was added conc. aq. HCl (5 mL). The ensuing mixture was salted out, 
where acid started precipitating from the solution. The mixture was extracted with ethyl 
acetate (50 mL). The organic phase was dried over anhydrous MgSO4 and concentrated 
in vacuo to dryness. The solid was taken up with hexane/ether (10:1) and filtered.  
The filter was air-dried to give 3-hydroxy-4-methoxyphenylpropionic acid (57c, 
638 mg, 76%) as a colourless solid, MP. 149 oC; vmax (KBr/cm
-1) 3398 (bs, OH), 2939, 
2847, 1703, 1519, 1446, 1306, 1276, 1213, 1135, 809, 766; δH (400 MHz, CDCl3)2.63 
(2H, t, 3J = 7.6 Hz), 2.85 (2H, t, 3J = 7.6 Hz), 3.85 (3H, s, OCH3), 5.90 (2H, bs), 6.67 (1H, 
dd, 3J = 8.0 Hz, 4J = 2.0 Hz), 6.76 (1H, d, 3J = 8.0 Hz), 6.77 (1H, d, 4J = 2.0 Hz); δC (67.8 
MHz, CDCl3) 30.0 (CH2), 35.7 (CH2), 56.0 (OCH3), 110.7 (CH), 114.5 (CH), 119.6 (CH), 
133.4 (Cquat), 145.1 (Cquat), 145.5 (Cquat), 178.5 (Cquat, CO). Variation B: To a mixture of 
3-hydroxy-4-methoxycinnamic acid (27e, 2.0 g, 10.3 mmol) and Pd/C (200 mg, 5 wt%, 
Aldrich 205680) in dioxane (10 mL) and toluene (15 mL) were added NaBH4 (1.18 g in 
33 
 
small portions) and acetic acid (1.33 g). After 36h, water (25 mL) was added carefully, 
followed by conc. aq. HCl (3 mL). The ensuing mixture was extracted with CH2Cl2 (3 X 
35 mL). The organic phase was dried over anhydrous MgSO4 and concentrated in vacuo 
to give compound 57c (1.38 g, 69%).  
N-Octyl 1,4-quinon-2-ylpropionamide (58a).  
To a stirred solution of compound 43g (900 mg, 3.07 mmol) in 
CH3CN (23 mL) was added at RT CAN (5.21 g, 9.50 mmol) in 
H2O (20 mL). The reaction mixture was stirred at RT for 10 min. Thereafter, H2O (30 
mL) was added and the mixture was extracted with CH2Cl2 (3 X 30 mL). The combined 
organic phase was dried over anhydrous MgSO4 and concentrated in vacuo. Column 
chromatography of the residue on silica gel (CH2Cl2/ether 10:1) gave compound 58a (412 
mg, 51%) as a red, slowly crystallizing oil; vmax (KBr/cm
-1) 2925, 2854, 1662 (bs), 1541, 
1492, 1466, 1286, 1039, 568; δH (400 MHz, CDCl3) 0.85 (3H, t, 
3J = 6.8 Hz, CH3), 1.20-
1.35 (10H, m), 1.54-1.61 (2H, m), 3.39 (2H, m), 6.78 (1H, d, 3J = 10.0 Hz), 6.82 (1H, dd, 
3J = 10.0 Hz, 4J = 2.4 Hz), 7.64 – 7.65 (1H, m), 8.31 (1H, bs, NH); δC (67.8 MHz, CDCl3) 
14.1 (CH3), 22.6 (CH2), 27.0 (CH2), 29.1(5) (2C, CH2), 29.2 (CH2), 31.7 (CH2), 40.1 
(NCH2), 134.7 (Cquat), 136.7 (CH), 137.1 (CH), 139.2 (CH), 160.8 (Cquat, NCO), 187.4 
(Cquat, CO), 188.4 (Cquat, CO); UV (CH2Cl2) λ = 325 (ε = 590); UV (CH3CN) λ= 325 nm, 
247 nm (sh). 
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Ethyl 5-methoxy-1,4-quinon-2-ylpropionate (64a). 
To compound 63 (450 mg, 2.00 mmol) in CH3CN (15 mL) was 
added dropwise a solution of CAN (3.47 g, 6.31 mmol) in H2O (25 
mL). The reaction mixture was stirred at RT for 15 min. Then, water 
(25 mL) was added and the mixture was extracted with CH2Cl2 (3 X 25 mL). The organic 
phase was dried over anhydrous MgSO4 and concentrated in vacuo. Column 
chromatography of the residue on silica gel (CH2Cl2/ether 2:1) gave compound 64a (250 
mg, 52.(5)%) as a yellow solid, MP. 114 oC; vmax (KBr/cm
-1) 3065, 2985, 1728, 1671, 
1644, 1603, 1299, 1268, 1234, 1194, 1179, 1058, 1027, 977, 914, 863, 786; δH (400 MHz, 
CDCl3) 1.23 (3H, t, 
3J = 7.2 Hz, CH3), 2.54 (2H, t, 
3J = 7.2 Hz), 2.75 (2H, dt, 3J = 7.2 Hz, 
4J = 0.9 Hz), 3.80 (3H, s, OCH3), 4.11 (2H, q, 
3J = 7.2 Hz, OCH2), 5.92 (1H, s), 6.51 (1H, 
t, 4J = 0.9 Hz); δC (67.8 MHz, CDCl3) 14.2 (CH3), 24.5 (CH2), 32.2 (CH2), 56.3 (OCH3), 
60.8 (OCH2), 107.7 (CH), 131.0 (CH), 148.5 (Cquat), 158.6 (Cquat), 172.0 (Cquat, CO), 182.1 
(Cquat, CO), 187.0 (Cquat, CO). UV (CH2Cl2) λ = 265 nm, 360 nm; UV (CH3CN) λ = 260 
nm, 360 nm. 
N-Benzyl 5-methoxy-1,4-quinon-2-ylpropionamide (64b).  
To a stirred solution of compound 43m (250 mg, 0.92 mmol) in 
CH3CN (15 mL) was added dropwise a solution of CAN (1.58 g, 
2.88 mmol) in H2O (15 mL). The reaction mixture was stirred at RT for 15 min. 
Thereafter, H2O (30 mL) was added and the mixture was extracted with CH2Cl2 (3 X 30 
mL). The combined organic phase was dried over anhydrous MgSO4 and concentrated in 
vacuo. Column chromatography of the residue on silica gel (CH2Cl2/ether 1:1) gave 
compound 64b (104 mg, 54%) as a yellow solid, MP. 158 oC; vmax (KBr/cm
-1) 3335, 1667, 
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1650, 1610, 1545, 1232, 1208, 1182; δH (400 MHz, CDCl3) 2.44 (2H, t, 
3J = 7.6 Hz), 2.79 
(1H, dd, 3J = 7.6 Hz, 4J = 1.6 Hz), 3.79 (3H, s, OCH3), 4.40 (2H, d, 
3J = 5.2 Hz), 5.78 
(1H, bs, NH), 5.88 (1H, s), 6.54 (1H, t, 4J = 1.6 Hz), 7.22 – 7.32 (5H, m); δC (67.8 MHz, 
CDCl3) 25.4 (CH2), 34.5 (CH2), 43.7 (NCH2), 56.3 (OCH3), 107.7 (CH), 127.6 (CH), 
127.9 (2C, CH), 128.8 (2C, CH), 131.3 (CH), 137.9 (Cquat), 148.5 (Cquat), 158.6 (Cquat), 
170.7 (Cquat, NCO), 182.0 (Cquat, CO), 187.3 (Cquat, CO); UV (CH2Cl2) λ= 265 nm (ε = 
5670 M-1cm-1), 351 nm (ε = 220 M-1cm-1); UV (CH3CN) λ= 260 nm (ε = 8140 M
-1cm-1), 
350 nm (ε = 490 M-1cm-1). 
N, N-Dipropyl 5-methoxy-1,4-quinon-2-ylpropionamide (64c).   
To compound 43e (225 mg, 0.81 mmol) in CH3CN (10 mL) was 
added dropwise a solution of CAN (1.39 g, 2.53 mmol) in H2O (15 
mL). The reaction mixture was stirred at RT for 15 min. Then, 
water (25 mL) was added and the mixture was extracted with 
CH2Cl2 (3 X 25 mL). The organic phase was dried over anhydrous MgSO4 and 
concentrated in vacuo. Column chromatography of the residue on silica gel (CH2Cl2/ether 
2:1) gave compound 64c (95 mg, 40%) as a yellow solid, MP. 85 oC; vmax (KBr/cm
-1) 
3064, 2962, 2931, 2873, 1674, 1647, 1605, 1455, 1423, 1239, 1207, 1180, 1145, 1049, 
982, 920, 868; δH (400 MHz, CDCl3) 0.83 – 0.91 (6H, m), 1.47 – 1.58 (4H, m), 2.53 (2H, 
dd, 3J = 7.6 Hz, 4J = 2.4 Hz), 2.76 (2H, t, 3J = 7.6 Hz), 3.15 (2H, t, 3J = 7.6 Hz), 3.23 (2H, 
t, 3J = 7.6 Hz), 3.79 (3H, s, OCH3), 5.90 (1H, s), 6.53 (1H, bs); δC (67.8 MHz, CDCl3) 
11.3 (CH3), 11.4 (CH3), 20.9 (CH2), 22.2 (CH2), 25.3 (CH2), 31.4 (CH2), 47.7 (NCH2), 
49.5 (NCH2), 56.2 (OCH3), 107.7 (CH), 131.1 (CH), 149.4 (Cquat), 158.6 (Cquat), 170.5 




1cm-1), 351 nm (ε = 220 M-1cm-1); UV (CH3CN) λ = 265 nm (ε = 13730 M
-1cm-1), λ = 355 
nm (ε = 550 M-1cm-1). 
 
N-Octyl 5-methoxy-1,4-quinon-2-ylpropionamide (64d).  
To a stirred solution of compound 43n (200 mg, 0.65 mmol) 
in CH3CN (15 mL) was added dropwise a solution of CAN 
(1.12 g, 2.04 mmol) in H2O (10 mL). The reaction mixture 
was stirred at RT for 15 min. Thereafter, H2O (30 mL) was 
added and the mixture was extracted with CH2Cl2 (3 X 30 mL). The combined organic 
phase was dried over anhydrous MgSO4 and concentrated in vacuo. Column 
chromatography of the residue on silica gel (CH2Cl2/ether 1:1) gave compound 64d as 
(137 mg, 65%) as a yellow solid; MP. 160 oC; vmax (KBr/cm
-1) 3337 (NH), 3062, 2918, 
2849, 1669, 1654 (s), 1614, 1530, 1242, 1207, 1184; δH (400 MHz, CDCl3) 0.86 (3H, t, 
3J = 6.8 Hz, CH3), 1.22 – 1.27 (10H, m), 1.42 – 1.48 (2H, m), 2.34 (2H, t, 
3J = 7.6 Hz), 
2.76 (2H, dt, 3J = 7.6 Hz, 4J = 1.2 Hz), 3.20 – 3.22 (2H, m), 3.80 (3H, s, OCH3), 5.54 (1H, 
bs, NH), 5.90 (1H, s), 6.54 (1H, t, 4J = 1.2 Hz); δC (67.8 MHz, CDCl3) 14.1 (CH3), 22.6 
(CH2), 25.3 (CH2), 26.9 (CH2), 29.1(5) (CH2), 29.2 (CH2), 29.5 (CH2), 31.8 (CH2), 34.5 
(CH2), 39.7 (NCH2), 56.3 (OCH3), 107.7 (CH), 131.2 (CH), 148.7 (Cquat), 158.6 (Cquat), 
170.9 (Cquat, NCO), 182.0 (Cquat, CO), 187.3 (Cquat, CO); UV (CH2Cl2) λ = 355 nm, 265 
nm; UV (CH3CN) λ = 351 nm, 260 nm. 
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N-Piperidinyl 5-methoxy-1,4-quinon-2-ylpropionamide (64e). 
 To a stirred solution of 43o (250 mg, 0.95 mmol) in CH3CN (15 
mL) was added at RT CAN (1.64 g, 3.00 mmol) in H2O (15 mL). 
The reaction mixture was stirred at RT for 10 min. Thereafter, H2O 
(30 mL) was added and the mixture was extracted with CH2Cl2 (3 X 30 mL). The 
combined organic phase was dried over anhydrous MgSO4 and concentrated in vacuo. 
Column chromatography of the residue on silica gel gave compound 64e (130 mg, 50%) 
as a bright yellow solid; MP. 154 oC; vmax (KBr/cm
-1) 2931, 2860, 1671, 1648 (s), 1634, 
1625, 1458, 1234, 1203, 1178, 1008, 916; δH (400 MHz, CDCl3) 1.50 – 1.56 (4H, m), 1.60 
– 1.64 (2H, m), 2.56 (2H, t, 3J = 7.2 Hz), 2.75 (2H, dd, 3J = 7.2 Hz, 4J = 1.4 Hz), 3.45 (4, 
bs), 3.80 (3H, s, OCH3), 5.90 (1H, s), 6.55 (1H, t, 
4J = 1.4 Hz); δC (67.8 MHz, CDCl3) 
24.4 (CH2), 25.2 (CH2), 31.5 (CH2), 56.3 (OCH3), 107.7 (CH), 131.2 (CH), 149.3 (Cquat), 
158.6 (Cquat), 169.3 (Cquat, CO), 182.2 (Cquat, CO), 187.4 (Cquat, CO). 
Silver (I) oxide. 
Ag2O was prepared from AgNO3 according to the procedure by D. E. Janssen and C. D. 
Wilson (Janssen and Wilson 1956): To an aq. solution of AgNO3 (crystalline, 27.4 g, 16.1 
mmol in 50 mL H2O) is added dropwise under stirring an aq. NaOH solution (NaOH [6.6 
g, 0.165 mol] in H2O [200 mL]). Immediately black-brown solid Ag2O developed. After 
the addition, the solid was collected on a sintered fritte and washed with water (3 X 50 




3-Cholesteryl 2,5-dimethoxyphenylpropionate (73).  
A solution of triphenylphosphine (PPh3, 910 g, 3.47 
mmol) and bromotrichloromethane (BrCCl3, 720 mg, 
3.63 mmol) in dry CH2Cl2 (10 mL) was stirred at RT 
for 35 min., during which time the solution turned 
yellow-orange. Thereafter, 2,5-dimethoxyphenylpropionic acid (57b, 510 mg, 2.43 
mmol) was added (as a solid), and the mixture was stirred at reflux for 40 min. Then, 
cholesterol (55, 940 mg, 2.43 mmol) was added as a solid, and the resulting mixture was 
stirred at reflux for 14 hr. The mixture was subjected directly to column chromatography 
on silica gel (CH2Cl2-hexane 3:1) to give compound 73 (890 mg, 63%) as a slowly 
crystallizing oil; MP. 70 oC; vmax (neat/cm
-1) 2954, 1733, 1502, 1465, 1375, 1222, 1163, 
1051, 1030, 799, 738, 709; δH (400 MHz, CDCl3) 0.65 (3H, s, CH3), 0.83 (3H, d, 
3J = 6.4 
Hz), 0.84 (3H, d, 3J = 6.4 Hz), 0.89 (3H, d, 3J = 6.4 Hz), 0.92 – 2.00 (26H, m), 0.99 (3H, 
s, CH3), 2.26 – 2.28 (2H, m), 2.55 (2H, t, 
3J = 7.6 Hz), 2.88 (2H, t, 3J = 7.6 Hz), 3.73 (3H, 
s, OCH3), 3.76 (3H, s, OCH3),4.55 – 4.63 (1H, m), 5.34 (1H, bd, 
3J = 5.2 Hz), 6.68 (1H, 
dd, 3J = 8.8 Hz, 4J = 3.2 Hz), 6.72 (1H, d, 4J = 3.2 Hz), 6.73 (1H, d, 3J = 8.8 Hz); δC (67.8 
MHz, CDCl3) 11.8, 14.1 19.3, 21.0, 22.5, 22.6, 22.8, 23.8, 24.3, 26.3, 27.7, 28.0, 28.2, 
31.8, 31.9, 34.5, 35.8, 36.1, 36.6, 37.0, 38.1, 39.5, 39.7, 55.6, 55.7, 56.1, 56.6, 73.8 (CH), 
111.0 (CH), 111.4 (CH), 116.3 (CH), 122.5 (Cquat), 130.1 (CH), 139.7 (Cquat), 151.7 
(Cquat), 153.3 (Cquat), 172.7 (Cquat, CO). 
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3-Cholesteryl 1,4-quinon-2-ylpropionate (74).  
To a mixture of 73 (980 mg, 1.69 mmol) in CH3CN 
(20 mL) was added a solution of CAN (2.87 g, 5.23 
mmol) in H2O (20 mL). Due to the very low solubility 
of crystalline 73 in CH3CN, CH2Cl2 (0.5 mL) was added during the reaction. The reaction 
mixture was stirred at RT for 30 min. Thereafter, H2O (30 mL) was added and the mixture 
was extracted with CHCl3 (3 X 30 mL). The combined organic phase was dried over 
anhydrous MgSO4 and concentrated in vacuo. The residue was subjected to column 
chromatography on silica gel (CH2Cl2-hexane 3:1) to give compound 74 (407 mg, 44%) 
as a yellow solid; MP. 148 oC; vmax (KBr/cm
-1) 2934, 2868, 1732, 1655, 1302, 1188, 1163, 
997, 924; δH (400 MHz, CDCl3) 0.65 (3H, s, CH3), 0.83 (3H, d, 
3J = 6.8 Hz, CH3), 0.84 
(3H, d, 3J = 6.4 Hz, CH3), 0.89 (3H, d, 
3J = 6.4 Hz, CH3), 0.92 – 2.00 (26H, m), 0.99 (3H, 
s, CH3), 2.27 (2H, bd, 
3J = 8.0 Hz), 2.53 (2H, t, 3J = 7.2 Hz), 2.73 (1H, dd, 3J = 7.2 Hz, 4J 
= 1.2 Hz), 4.55 – 4.63 (1H, m), 5.34 (1H, bd, 3J = 5.2 Hz), 6.57 (1H, d, 4J = 2.0 Hz), 6.71 
(1H, dd, 3J = 10.0 Hz, 4J = 2.0 Hz), 6.75 (1H, d, 3J = 10.0 Hz), δC (67.8 MHz, CDCl3) 
11.8 (CH3), 18.7, 19.3, 21.0, 22.5, 22.8, 23.8, 24.3, 24.6, 27.7, 28.0, 28.2, 31.8, 31.8(5), 
32.3, 35.8, 36.1, 36.5, 38.1, 39.5, 39.7, 42.3, 49.9, 56.1, 56.6, 77.3 (CH), 122.8 (CH), 
133.0 (CH), 136.4 (CH), 136.8 (CH), 139.4 (Cquat), 147.6 (Cquat), 171.3 (Cquat, CO), 187.1 
(Cquat, CO), 187.4 (Cquat, CO); UV (CH3CN) λ = 305.0 nm (ε = 656), 249.9 nm (ε = 14960); 
(CH2Cl2) λ = 310.0 nm, 249.9 nm. 
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2,5-Dimethoxybenzoic acid (75). 
 To freshly prepared Ag2O (moist, 7.5 g) in an aq. NaOH solution 
(NaOH [1.5 g, 37.5 mmol] in H2O [40 mL]) was added under stirring 
2,5-dimethoxybenzaldehyde (5.0 g, 30.1 mmol). After an induction time of 20-25 min., 
the solution became warm. After 14 hr., the solution was filtered through a paper filter. 
The filter cake was washed diligently with water (3 X 25 mL). The filtrate was acidified 
with half-conc. HCl.The mixture was extracted with ethyl acetate (75 mL). The organic 
phase was dried over anhydrous MgSO4 and concentrated in vacuo to give compound 75 
(4.72 g, 86%) as colorless needles, MP. 70 oC (Lit. 74.5 – 76.5 oC [Henton et al. 1980]); 
vmax (KBr/cm
-1) 3428 (bs, OH), 2950, 2836, 1732, 1500, 1434, 1295, 1215, 1179, 1045, 
1013, 812, 727; δH (400 MHz, CDCl3) 3.81 (3H, s, OCH3), 4.03 (3H, s, OCH3), 6.98 (1H, 
d, 3J = 8.8 Hz), 7.10 (1H, dd, 3J = 8.8 Hz, 4J = 3.2 Hz), 7.67 (1H, d, 4J = 3.2 Hz); δC (67.8 
MHz, CDCl3) 55.9 (OCH3), 57.2 (OCH3), 113.2 (CH), 116.2 (CH), 117.9 (Cquat), 122.1 
(CH), 152.2 (Cquat), 154.4 (Cquat), 165.2 (Cquat, CO). 
Cholesteryl 2,5-dimethoxybenzoate (76).  
A solution of triphenylphosphine (PPh3, 910 g, 3.47 
mmol) and bromotrichloromethane (BrCCl3, 720 mg, 
3.63 mmol) in dry CH2Cl2 (10 mL) was stirred at RT for 
35 min., during which time the solution turned yellow-orange. Thereafter, 2,5-
dimethoxybenzoic acid (75, 500 mg, 2.80 mmol) was added (as a solid), and the mixture 
was stirred at reflux for 40 min.  Then, cholesterol (940 mg, 2.43 mmol) was added as a 
solid, and the resulting mixture was stirred at reflux for 14h. Direct column 
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chromatography of the reaction mixture on silica gel (CH2Cl2-hexane 3:1) gave 
compound 76 (878 mg, 64%) as a colorless solid, MP. 119 oC; δH (400 MHz, CDCl3)0.67 
(3H, s, CH3), 0.84 (3H, d, 
3J = 6.0 Hz, CH3), 0.85 (3H, d, 
3J = 6.4 Hz, CH3), 0.90 (3H, d, 
3J = 6.4 Hz, CH3), 0.92 – 2.00 (26H, m), 1.03 (3H, s, CH3), 2.42 – 2.48 (2H, m), 3.78 (3H, 
s, OCH3), 3.83 (3H, s, OCH3), 4.79 – 4.87 (1H, m), 5.39 (1H, bd, 
3J = 5.6 Hz), 6.89 (1H, 
d, 3J = 8.8 Hz), 6.98 (1H, dd, 3J = 8.8 Hz, 4J = 3.6 Hz), 7.28 (1H, d, 4J = 3.6 Hz); δC (67.8 
MHz, CDCl3) 11.8 (CH3), 18.7 (CH3), 19.4 (CH3), 21.0, 22.6, 22.8, 23.8, 24.3, 27.8, 28.0, 
28.2, 31.8, 31.9, 35.8, 36.2, 36.6, 37.0, 38.1, 39.4, 39.7, 42.3, 50.0, 55.8, 56.1, 56.7, 56.9, 
74.6 (CH), 113.9 (CH), 116.0 (CH), 118.8 (CH), 121.4 (Cquat), 122.7 (CH), 139.7 (Cquat), 
153.0 (Cquat), 153.4 (Cquat), 165.4 (Cquat, CO). 
3-Cholesteryl quinonylcarboxylate (77).  
To a stirred solution of compound 76 (870 mg, 1.54 
mmol) in a solvent mixture of CH2Cl2 (5 mL) and 
CH3CN (15 mL) was added CAN (2.67 g, 4.86 mmol) 
in H2O (10 mL). The reaction mixture was stirred for 1h at RT. Then, H2O (30 mL) was 
added and the mixture was extracted with CH2Cl2 (3 X 30 mL). The combined organic 
phase was dried over anhydrous MgSO4 and concentrated in vacuo. Column 
chromatography of the residue on silica gel (CH2Cl2 – hexane 3:1) yielded compound 77 
as an orange solid, MP. 158 oC; vmax (KBr/cm
-1) 3051, 2933, 2867, 2850, 1740 (s), 1663 
(s), 1467, 1252, 1040, 842; δH (400 MHz, CDCl3) 0.66 (3H, s, CH3), 0.84 (3H, d, 
3J = 6.4 
Hz), 0.84(5) (3H, d, 3J = 6.4 Hz), 0.90 (3H, d, 3J = 6.0 Hz), 0.92 – 2.02 (26H, m), 1.01 
(3H, s, CH3), 2.40 – 2.42 (2H, m), 4.78 – 4.86 (1H, m), 5.40 (1H, bd, 
3J = 5.2 Hz), 6.80 
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(2H, m), 7.02 – 7.04 (2H, m); δC (67.8 MHz, CDCl3) 11.8 (CH3),18.7, 19.3, 21.0, 22.5, 
22.8, 23.8, 24.3, 27.6, 28.0 (2C), 28.2, 31.8, 31.9, 35.8, 36.1, 36.5, 39.5, 39.7, 42.3, 
49.9,56.1, 56.6, 76.5 (CH), 123.3 (CH), 135.7 (CH), 136.1 (CH), 136.9 (CH), 137.7 
(Cquat), 139.0 (Cquat), 162.1 (Cquat, CO), 183.2 (Cquat, CO), 187.0 (Cquat, CO); UV (CH3CN) 
λ = 325.0 nm, 244.9 nm; (CH2Cl2) λ = 325.0 nm, 249.9 nm. 
3-Cholesteryl 3-hydroxy-4-methoxy phenyl propionate (78).  
A solution of triphenylphosphine (PPh3, 854 mg, 
3.26 mmol) and tetrachloromethane (CCl4, 550 mg, 
3.58 mmol) in dry CH2Cl2 (12 mL) was stirred at 
reflux for 50 min. Then, 3-hydroxy-4-methoxy 
phenylpropionic acid (57c, 535 mg, 2.73 mmol) was added, and the mixture was stirred 
at reflux for 1h. Then, cholesterol (55, 1.585 g, 4.1 mmol) was added, and the resulting 
mixture was stirred at reflux for 14 hr. The mixture was subjected directly to column 
chromatography on silica gel (eluant: CH2Cl2) to give compound 78 (960 mg) as a 
colorless solid, MP. 130 oC; vmax (KBr/cm
-1) 3922 (ds, OH), 2939, 2903, 2866, 2850, 
1698, 1592, 1536, 1465, 1437, 1364, 1255, 1213, 1129, 1032, 875, 801; δH (400 MHz, 
CDCl3) 0.65 (3H, s, CH3), 0.84 (3H, d, 
3J = 6.0 Hz, CH3), 0.84(5) (3H, d, 
3J = 6.4 Hz, 
CH3), 0.89 (3H, d, 
3J = 6.4 Hz, CH3), 0.92 – 2.01 (26H, m), 0.99 (3H, s, CH3), 2.27 (2H, 
bd, J = 8.0 Hz), 2.54 (2H, t, 3J = 7.6 Hz), 2.83 (2H, d, 3J = 7.6 Hz), 3.84 (3H, s, OCH3), 
4.55 – 4.63 (1H, m), 5.34 (1H, bd, 3J = 4.0 Hz), 5.53 (1H, bs, OH), 6.65 (1H, dd, 3J = 8.0 
Hz, 4J = 2.0 Hz), 6.75 (1H, d, 3J = 8.0 Hz), 6.76 (1H, d, 4J = 2.0 Hz); δC (67.8 MHz, 
CDCl3) 11.8 (CH3), 18.7, 19.3, 21.0, 22.6, 22.8, 23.8, 24.3, 27.7, 28.0, 28.2, 30.4, 31.8 
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(2C), 31.9, 35.8, 36.1 (5), 36.4, 36.6, 36.9 (5), 38.1, 39.5, 39.7, 42.3, 50.0, 55.9 (5), 56.1, 
56.6, 74.0 (CH), 110.6 (CH), 114.5 (CH), 119.6 (CH), 122.6 (CH), 133.9 (Cquat), 139.6 
(Cquat), 144.9 (Cquat), 145.4 (Cquat), 172.4 (Cquat, CO). 
Cholesteryl 5-methoxy-1,4-quinon-2-ylpropionate (79). 
 To a stirred solution of compound 78 (265 mg, 
0.47 mmol) in a solvent mixture of CH2Cl2 (5 
mL) and CH3CN (10 mL) was added CAN (810 
mg, 1.47 mmol) in H2O (10 mL). The reaction 
mixture was stirred for 15 min. at RT. Then, H2O (30 mL) was added and the mixture was 
extracted with CH2Cl2(3 X 30 mL). The combined organic phase was dried over 
anhydrous MgSO4 and concentrated in vacuo. Column chromatography of the residue on 
silica gel (CH2Cl2/ ether 5:1) yielded 79 (145 mg) as a yellow-brown solid, MP. 202 
oC; 
vmax (KBr/cm
-1) 2938, 2867, 1732, 1671, 1649, 1606, 1465, 1374, 1172, 980; δH (400 
MHz, CDCl3) 0.65 (3H, s, CH3), 0.84 (3H, d, 
3J = 6.8 Hz), 0.84(5) (3H, d, 3J = 6.4 Hz), 
0.89 (3H, d, 3J = 6.8 Hz), 0.86 – 1.85 (24H, m), 0.99 (3H, s, CH3), 1.92 – 2.01 (2H, m), 
2.27 (2H, d, 3J = 7.6 Hz), 2.52 (2H, t, 3J = 7.2 Hz), 2.74 (2H, dt, 3J = 7.2 Hz, 4J = 0.8 Hz), 
3.80 (3H, s, OCH3), 4.55 – 4.63 (1H, m), 5.35 (1H, d, 
3J = 3.6 Hz), 5.92 (1H, s), 6.51 (1H, 
t, 4J = 0.8 Hz); δC (67.8 MHz, CDCl3) 11.8 (CH3), 18.7 (CH3), 19.3 (CH3), 21.0, 22.5, 
22.8, 23.8, 24.3, 24.6, 27.7, 28.0 (2C), 28.2, 31.8, 31.9, 32.5, 35.8, 36.1, 36.5, 36.9, 38.1, 
39.5, 39.7, 42.3, 50.0, 56.1, 56.3, 56.6, 74.4 (CH), 107.7 (CH), 122.8, 131.0, 139.4, 148.5, 
158.6, 171.3 (Cquat, CO), 182.1 (Cquat, CO), 187.0 (Cquat, CO); UV (CH2Cl2) λ = 360 nm 
(ε = 585), λ  = 249.9 nm (ε = 12850). 
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3-Methoxyestra-1,3,5(10)-trien-17β-yl 2,5-(E)-dimethoxycinnamate (82) 
To a solution of triphenylphosphine (PPh3, 582 mg, 
2.22 mmol) in dry CH2Cl2 (7 mL) was given BrCCl3 
(460 mg, 2.32 mmol). The ensuing mixture was 
stirred at RT for 30 min., during which time it turned dark orange. Thereafter, 2,5-
methoxycinnamic acid (420 mg, 2.02 mmol) was added portionwise, and the resulting 
reaction mixture was stirred under reflux for 45 min. Then, 3-O-methylestra-1,3,5(10)-
trien-3,17β-diol (81, 275 mg, 0.96 mmol) was added, and the mixture was stirred under 
reflux for another 12h. At certain intervals, the reaction vessel is set under slight vacuum 
(alternatively, 0.96 mmol dry DBU or dry Et3N can be added to the reaction 15 min. after 
the addition of the steroid). Direct column chromatography of the cooled, concentrated 
solution on silica gel (CHCl3/ Et2O/ hexane 1:1:1) 2,5-methoxyestra-1,3,5(10)-trien-17β-
yl 4-(E)-methoxycinnamate (82) (330 mg, 72%)as a colorless solid, MP. 139-140 oC; vmax 
(KBr/cm-1) 3008, 2923, 2867, 2835, 1709, 1629, 1499, 1464, 1447, 1335, 1294, 1258, 
1227, 1178, 1040, 997, 859, 819, 702, 560; δH (400 MHz, CDCl3) 0.91 (3H, s, CH3), 1.32 
– 2.32 (13H, m), 2.84 – 2.87 (2H, m), 3.77 (3H, s, OCH3), 3.79 (3H, s, OCH3), 3.84 (3H, 
s, OCH3), 4.84 (1H, dd, 
3J = 8.8 Hz, 3J = 8.0 Hz, OCH), 6.50 (1H, d, 3J = 16.0 Hz), 6.63 
(1H, d, 4J = 2.8 Hz), 6.71 (1H, dd, 3J = 8.8 Hz, 4J = 2.8 Hz), 6.84 (1H, d, 3J = 9.2 Hz), 
6.90 (1H, dd, 3J = 9.2 Hz, 4J = 3.2 Hz), 7.06 (1H, d, 4J = 3.2 Hz), 7.21 (1H, d, 3J = 8.8 
Hz), 7.97 (1H, d, 3J = 16.0 Hz); δC (100.5 MHz, CDCl3) 12.2, 23.3, 26.3, 27.3, 27.7, 29.8, 
37.0, 38.6, 43.2, 43.8, 49.8, 55.2 (OCH3), 55.8 (OCH3), 56.1 (OCH3), 82.7 (OCH), 111.5, 
112.4, 113.2, 113.8, 117.0, 119.2, 124.0, 126.4, 132.6, 137.9, 139.6, 152.8 (Cquat), 153.5 
(Cquat), 157.4 (Cquat), 167.5 (Cquat, CO). 
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3-Methoxyestra-1,3,5(10)-trien-17β-yl 3,4-(E)-dimethoxycinnamate(82-3,4-di-OMe)  
As a colorless solid, MP. 162-165 oC; vmax (KBr/cm
-1) 
3010, 2953, 2863, 2843, 2805, 2698, 1612, 1596, 1510, 
1445, 1417, 1294, 1257, 1155, 1139, 1024, 848, 812, 
782, 616, 570; δH (400 MHz, CDCl3) 0.90 (3H, s, CH3), 
2.84 – 2.88 (2H, m), 1.25 – 2.31 (13H, m), 3.77 (3H, s, OCH3), 3.91 (3H, s, OCH3), 3.92 
(3H, s, OCH3), 4.83 (1H, dd, 
3J = 8.0, 3J = 7.6 Hz, OCH), 6.32 (1H, d, 3J = 16.0 Hz), 6.63 
(1H, d, 4J = 2.8 Hz), 6.70 (1H, dd, 3J = 8.4 Hz, 4J = 2.8 Hz), 6.86 (1H, d, 3J = 8.4 Hz), 
7.05 (1H, d, 4J = 2.0 Hz), 7.10 (1H, dd, 3J = 8.4 Hz, 4J = 2.0 Hz), 7.20 (1H, d, 3J = 8.4 
Hz), 7.61 (1H, d, 3J = 16.0 Hz); δC  (100.5 MHz, CDCl3) 12.2, 23.3, 26.2, 27.2, 27.7, 29.8, 
37.0, 38.6, 43.2, 43.8, 49.8, 55.2 (OCH3), 55.9 (OCH3), 56.0 (OCH3), 82.7 (OCH), 109.5, 
111.0, 111.5, 113.8, 116.2, 122.6, 126.4, 127.5, 132.5, 137.9, 144.3, 149.2 (Cquat), 151.0 
(Cquat), 157.4 (Cquat), 167.3 (Cquat, CO). Found: C, 75.76%; H, 7.32%. Calcd. for C30H36O5 
.(476.60): C, 75.60%; H, 7.61%. 
3-Methoxyestra-1,3,5(6)-trien-17-yl 3-(2,5-dimethoxyphenyl) propionate (83). 
To a solution of 3-methoxyestra-1,3,5(6)-trien-17-yl 
2,5-dimethoxycinnamate (82, 500 mg, 1.05 mmmol) 
and Pd/C (100 mg, 5wt%, Aldrich 205680) in toluene 
(10 mL) was added AcOH (235 mg, in successive 
portions of 150 mg and 85 mg) and NaBH4 (280 mg, in successive portions of 150 mg 
and 130 mg). The mixture was stirred for 36 hr. at RT. Thereafter, H2O (3 mL) was added 
carefully, followed by half-conc. aq. HCl (3 mL). The mixture was taken up in water (25 
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mL) and extracted with CH2Cl2 (3 X 30 mL). The organic phase was dried over anhydrous 
MgSO4 and concentrated in vacuo. The residue was subjected to column chromatography 
on silica gel (CH2Cl2-hexane 3:1, then CH2Cl2) to give compound 83 (500 mg, quant.) as 
a slowly crystallizing colorless oil; vmax (neat/cm
-1) 2928, 1727, 161, 1502, 1049, 869, 
808; δH (400 MHz, CDCl3) 0.77 (3H, s, CH3), 1.25 – 2.28 (13H, m), 2.61 (2H, t, 
3J = 8.0 
Hz), 2.83 – 2.85 (2H, m), 2.91 (2H, t, 3J = 8.0 Hz), 3.75 (3H, s, OCH3), 3.77 (3H, s, 
OCH3), 3.78 (3H, s, OCH3), 4.68 (1H, dd, 
3J = 8.8 Hz, 3J = 7.6 Hz), 6.62 (1H, d, 4J = 2.8 
Hz), 6.68 – 6.77 (4H, m), 7.19 (1H, d, 3J = 8.4 Hz); δC (67.8 MHz, CDCl3) 12.0, 23.7, 
26.2, 26.4, 27.2, 27.6, 29.8, 34.4, 36.8, 38.6, 42.9, 43.8, 49.7, 55.2, 55.7, 55.8, 82.6, 111.0, 
111.4, 111.4 (5), 113.7, 116.3, 126.4, 130.0, 132.5, 137.9, 151.7, 153.3, 157.4, 173.4. 
 
 
3-O-Methylestra-1,3,5(6)-trien-17-yl 3-(1.4-quinon-2-yl) propionate (84).  
To a solution of 73 (370 mg, 0.775 mmol) in a solvent 
mixture of CH3CN (10 mL) and CH2Cl2 was added 
dropwise CAN (1.34 g, 2.44 mmol) in water (10 mL), 
and the resulting reaction mixture was stirred for 35 min. 
at RT.  Column chromatography on silica gel (CH2Cl2-ether 20:1) gave compound 74 
(120 mg, 35%) as a yellow-orange, slowly crystallizing oil; vmax (neat/cm
-1) 2926, 1727, 
1659, 1610, 1502, 1444, 1255, 1081, 1038, 911, 870, 816, 728, 648; δH (400 MHz, CDCl3) 
0.79 (3H, s, CH3), 1.24 – 2.28 (13H, m), 2.57 (2H, t, 
3J = 7.0 Hz), 2.76 (2H, t, 3J = 7.0 
Hz), 2.82 – 2.84 (2H, m), 3.75 (3H, s, OCH3), 4.67 (1H, dd, 
3J = 8.8 Hz, 3J = 7.6 Hz), 
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6.58 - 6.59 (1H, m), 6.61 (1H, d, 4J = 2.8 Hz), 6.68 (1H, dd, 3J = 8.4 Hz, 4J = 2.8 Hz), 
6.72 (1H, d, 4J = 2.0 Hz), 6.76 (1H, d, 3J = 10.0 Hz), 7.17 (1H, d, 3J = 8.4 Hz); δC (100.5 
MHz, CDCl3) 12.1 (CH3), 23.2, 24.7, 26.2, 27.2, 27.6, 29.8, 32.2, 36.9, 38.5, 42.9, 43.7, 
49.6, 55.2 (OCH3), 83.2 (OCH), 111.5, 113.8, 126.3, 132.4, 132.9, 136.4, 136.8, 137.8, 
147.6, 157.4, 172.0 (Cquat, CO), 187.1 (Cquat, CO), 187.4 (Cquat, CO); MS (FAB, 3-
nitrobenzyl alcohol) m/z (%) 449 (M+, 3). 
3-Methoxyestra-1,3,5(6)-trien-17-yl 3-(3,4-dimethoxyphenyl)propionate) (89).  
To a solution of3-methoxyestra-1,3,5(6)-trien-
17-yl 3,4-dimethoxycinnamate (82-3,4-di-
OMe, 314 mg, 0.66 mmmol) and Pd/C (100 mg, 
5wt%, Aldrich 205680) in toluene (10 mL) was 
added AcOH (235 mg, in successive portions of 150 mg and 85 mg) and NaBH4 (280 mg, 
in successive portions of 150 mg and 130 mg). The mixture was stirred for 36h at RT. 
Thereafter, H2O (3 mL) was added carefully, followed by half-conc. aq. HCl (3 mL). The 
mixture was taken up in water (25 mL) and extracted with CH2Cl2 (3 X 30 mL). The 
organic phase was dried over anhydrous MgSO4 and concentrated in vacuo. The residue 
was subjected to column chromatography on silica gel (CH2Cl2-hexane 3:1, then CH2Cl2) 
to give compound 89 (315 mg, quant.) as a slowly crystallizing colorless oil; vmax 
(neat/cm-1) 2932, 1732, 1609, 1516, 1456, 1257, 1031, 962, 890, 849, 809, 754, 667; δH 
(400 MHz, CDCl3) 0.77 (3H, s, CH3), 1.25 – 2.28 (13H, m), 2.61 (2H, t, 
3J = 8.0 Hz), 2.83 
– 2.85 (2H, m), 2.90 (2H, t, 3J = 8.0 Hz), 3.76 (3H, s, OCH3), 3.85 (3H, s, OCH3), 3.86 
(3H, s, OCH3), 4.68 (1H, dd, 
3J = 8.8 Hz, 3J = 7.6 Hz), 6.62 (1H, d, 4J = 2.4 Hz), 6.68 – 
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6.80 (4H, m), 7.18 (1H, d, 3J = 8.4 Hz); δC (67.8 MHz, CDCl3) 12.1, 23.3, 26.2, 27.2, 27.5, 
29.8, 30.7, 36.4, 36.8, 38.5, 42.9, 43.8, 49.7, 55.2, 55.8, 55.9, 82.7, 111.2, 111.4, 111.5, 
113.7, 120.1, 126.4, 132.4, 133.2, 137.9, 147.4, 148.8, 157.4, 173.1. 
N-Octyl 2-bromo-5-hydroxy-4-methoxyphenylpropionamide (91).  
To a solution of N-octyl 5-hydroxy-4-methoxyphenyl 
propionamide (43n, 220 mg, 0.66 mmol) in DMF (3 mL) 
was given at RT N-bromosuccinimide (150 mg, 0.83 
mmol, 1.25 eq.) in multiple portions over a period of 24 h. 
The reaction mixture was stirred a total of 36h. Then, H2O (25 mL) was added and the 
mixture was extracted with CHCl3 (3 X 20 mL). The combined organic phase was dried 
over anhydrous MgSO4 and evaporated in vacuo. Remaining DMF was co-evaporated 
with ether. The residue was subjected to column chromatography on silica gel (CH2Cl2-
ether 5:1) to give compound 91 (216 mg, 85%) as a colorless solid; vmax (KBr/cm
-1) 3303 
(bs, OH), 2929, 2856, 1644, 1556, 1504, 1441, 1280, 1208, 1161, 1034, 870, 795; δH (400 
MHz, CDCl3) 0.86 (3H, t, 
3J = 7.0 Hz, CH3), 1.23 – 1.27 (10H, m), 1.40 – 1.46 (2H, m), 
2.43 (2H, t, 3J = 7.8 Hz), 2.95 (2H, t, 3J = 7.8 Hz), 3.18 – 3.23 (2H, m), 3.84 (3H, s, 
OCH3), 5.45 (1H, bs), 6.82 (1H, s), 6.96 (1H, s); δC (67.8 MHz, CDCl3) 14.1 (CH3), 22.6 
(CH2), 26.8 (CH2), 29.2 (CH2), 29.2(5) (CH2), 29.5 (CH2), 31.7 (CH2), 31.8 (CH2), 36.8 
(CH2), 39.7 (CH2), 56.2 (OCH3), 112.8 (Cquat), 114.9 (CH), 116.2 (CH), 132.6 (Cquat), 





N-Benzyl 2,6-dibromo-5-hydroxy-4-methoxyphenylpropionamide (92). 
To a solution of N-octyl 5-hydroxy-4-methoxyphenyl 
propionamide (43m, 120 mg, 0.42 mmol) in DMF (1.5 
mL) was given at RT N-bromosuccinimide (160 mg, 0.9 
mmol, 2.05 eq.) in multiple portions over a period of 24 
hr. The reaction mixture was stirred a total of 48h. Then, H2O (25 mL) was added and the 
mixture was extracted with CHCl3 (3 X 20 mL). The combined organic phase was dried 
over anhydrous MgSO4 and evaporated in vacuo. Remaining DMF was co-evaporated 
with ether. The residue was subjected to column chromatography on silica gel (CH2Cl2-
ether 5:1) to give compound 92 (185 mg, 82%) as a colorless solid, MP. 208 oC; vmax 
(KBr/cm-1) 3415, 3297, 1638, 1033 (s), 696; δH (400 MHz, CDCl3) 2.42-2.44 (2H, m), 
3.27-3.31 (2H, m), 3.87 (3H, s, OCH3), 4.45 (2H, d, 
3J = 5.2 Hz, NCH2), 5.71 (1H, bs), 








Chapter 3: Results and Discussion 
3.1 Preparation of Cinnamic Acids As Starting Materials 
As it was planned to derive the quinone moiety from a hydroxylated or 
methoxylated arene, it is necessary to have a good access to hydroxylated or methoxylated 
phenylpropionic acids. It is planned to prepare the phenylpropionic acids by 
hydrogenation of the respective cinnamic acids. Thus, it became essential to find an easy 
access to cinnamic acids. Cinnamic acids are well-studied compounds that are produced 
industrially as well as cinnamic acid and derivatives find uses in the food industry 
(Cirigliano et al. 1997; Shahadi and Zhong 2010), and the cosmetic industry (L. Breton et 
al. 1997), among others. Additionally, cinnamic acids are important starting materials for 
a number of industrial syntheses, such as for the industrial preparation of phenylalanine 
and of aspartame (via phenylalanine) (Szmant 1989). Thus, a larger number of syntheses 
of cinnamic acids have been carried out. Among them are the reaction of benzaldehydes 
with malonic acid ester (Knoevenagel reaction with subsequent decarboxylation) 
(Mobinikhaledi et al. 2008; Gupta and Wakhloo 2007), of benzaldehydes with acetic 
anhydride/sodium acetate (Perkin reaction) (Johnson 1942), and of iodoarenes with 
acrylates via Heck reaction (Carmichael et al. 1999) with subsequent hydrolysis in a two-
step sequence. Recently, Knoevenagel type reaction has also been carried out with 
Meldrum’s acid (Zolfigol 2015).  
In Thiemann group the Heck reaction to cinnamates has only been used once 
(Burmester et al. 2010), and the yields of Knoevenagel and Perkin reactions have been 
found to be unpredictable, often. On the other hand, the Wittig reaction of benzaldehydes 
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with alkoxycarbonylmethylidenetriphenylphosphoranes gives cinnamates in dependable 
and good yields. While the reaction even with conjugated phosphoranes have been carried 
out in benzene or chloroform as solvents and oftentimes under an inert atmosphere, it has 
been found more recently that the alkoxycarbonylmethylidenetriphenylphosphoranes 
react selectively with the keto and aldehyde carbonyl function, but not with oxygen or 
water, even under slightly elevated temperatures. This has led to carrying out the Wittig 
reactions of aldehydes with alkoxycarbonylmethylidenetriphenylphosphoranes under 
various conditions (Odinets and Matveeva 2010, Al Jasem et al. 2014), including under 
solventless conditions (Thiemann 2007; Watanabe et al. 2005; Thiemann et al. 2004) and 
in aqueous medium (Dambacher et al. 2005; Wu et al. 2005A; Wu et al. 2005B; 
Yamamoto et al. 2005; Watanabe et al. 2005; Wu et al. 2006; Orsini et al. 2006; El Batta 
et al. 2007; Tiwari and Kumar 2008; McNulty and Das 2009). Apart from running Wittig 
reactions of benzaldehydes with alkoxycarbonylmethylidenetriphenylphosphorane with 
minimal solvent to acquire the alkyl cinnamates with a subsequent hydrolysis of the 
cinnamates with aq. NaOH/MeOH, this led the Thiemann group to try and synthesize 
cinnamic acids by a one-pot Wittig olefination – hydrolysis, when running the Wittig 
reactions in 2M aq. NaOH solutions (Thiemann et al. 2010; Thiemann et al. 2016). The 
cinnamic acids could be isolated by simple fitration after acidification of the reaction 
mixture with half-conc. aq. HCl. The filtered, air-dried products could be used for the next 
reaction step (Table 1). Here, both strategies were followed. 
First, the stabilized ethoxycarbonylmethylidenetriphenylphosphorane (23) had to 
be prepared (Considine 1962). For this, triphenylphosphine was reacted with ethyl 
bromoacetate in CHCl3. The product ethoxycarbonylmethyltriphenylphosphonium 
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bromide could be crystallized from ether. After decanting the solvent, the phosphonium 
bromide was dehydrobrominated in aq. Na2CO3. For the reaction, a small amount of 
CH2Cl2 was added so that the phosphorane would collect in the CH2Cl2 phase as the 
reaction proceeds. Afterwards, the CH2Cl2 phase was evaporated to give the phosphorane 




Scheme 6 : Preparation of ethoxycarbonylmethylidenetriphenylphosphorane 
 
Next, some the alkoxylated aldehydes had to be synthesized from the 
corresponding hydroxybenzaldehydes by Williamson type ether synthesis (Johnstone and 
Rose 1979, Scheme 7). 
 
Scheme 7: Preparation of alkoxylated benzaldehydes by Williamson-type synthesis 





Scheme 8: One step synthesis of cinnamic acids using Wittig olefination hydrolysis 
 
For the two step Wittig olefination (Scheme 9) – hydrolysis, first benzaldehyde 
and phosphorane were reacted in a minimum amount of solvent (Thiemann et al. 2006). 
The cinnamate gained as product was isolated by column chromatography. Then, the alkyl 
cinnamate was reacted in a mixture of aq. NaOH/MeOH at 90 oC to the respective 
cinnamic acids. For the one-pot Wittig olefination – hydrolysis reaction, an aq. solution 
of 2M aq. NaOH was added to a mixture of benzaldehyde and phosphorene, and the 
resulting mixture was heated to 95 oC. After the reaction was complete, it was cooled to 
RT. During this time two phases could be seen, that is oil droplets in water. As the reaction 
cooled and the stirring stopped the oil droplets partially coalesced. At some point, 
crystallization set in. The crystallized triphenylphosphine oxide was filtered off, washed 
diligently with 2M aq. NaOH and water, dried and collected. The aqueous phase was 
acidified with half conc. aq. HCl. The warm acidified solution was allowed to cool and 
stand for some time for the crystallization of the respective cinnamic acids to be complete. 
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Sometimes it was beneficial to salt out for a complete crystallization. The cinnamic acids 
had to be dried carefully for the next step as the Appel type transformations are very 
sensitive towards water/moisture. 
 
 
 Scheme 9: Two step synthesis of hydroxylated/alkoxylated cinnamic acids 
 
It is known that some benzaldehydes do not give the cinnamic acids under the one-
pot conditions. 4-Nitrobenzaldehyde and 2-nitrobenzaldehyde are two described 
examples (Thiemann et al. 2010, Thiemann et al., 2016). 2-Hydroxybenzaldehydes, such 
as 2,4-dihydroxybenzaldehyde do not undergo the reaction successfully. So, the hydroxy 





3.2 The Reactions of Linking Alcohols and Amines to Carboxylic Acids 
Under Mild Conditions Utilizing a Modified Appel-Type Reaction 
For the linking of the steroid to the precursor of the bioactive moiety or the halogen 
containing moiety in form of an ester or an amide, a simple reaction was looked for that 
would not need the preparation and isolation of a reactive acyl species such as an acyl 
halide (conversion of each acid component to the respective acyl halide), which our 
laboratory is not equipped for. The Fischer esterification needs in most of its variants 
elevated temperatures (Ishihara et al. 2005, Komura et al. 2008, Chakraborti et al. 2009), 
mostly above 80 oC, which was not suitable for our purposes. An interesting alternative 
is the Steglich esterification (Neises and Steglich), which uses p-N,N-dimethylamino 
pyridine (DMAP) and dicyclohexylcarbodiimide (DCC). The reaction can be altered and 
used for amidations of acids as well. In Thiemann group, this reaction has often been 
found difficult to perform as remainders of dicyclohexylcarbodiimide cannot be separated 
adequately from the product. Lastly, the Yamaguchi esterification (Inanaga et al. 1979, 
Dhimitruka and SantaLucia 2006) utilizes only one, commercially available acid chloride, 
namely the Yamaguchi reagent (2,4,6-trichlorobenzoyl chloride), together with DMAP, 
without having to convert each carboxylic acid to be converted to the corresponding acyl 
chloride. Because of lack of our experience with this reaction, it was decided to rather use 
a variation of the Appel-type esterification/amidation. It was also used to link acids to 
oximes in form of O-acyloximes (Al Azani et al. 2016). 
The Appel name reaction is connected to the transformation of an alcohol to an 
alkyl chloride (Calzada and Hooz 1974, Appel 1975) using a combination of 
triphenylphosphine (PPh3) and tetrachlorocarbon (CCl4). The reagent PPh3/CCl4, 
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however, is also useful as a dehydrating reagent and transforms carboxylic acids into 
activated forms in situ such as to acyl chlorides. These can then be reacted with amines to 
carboxamides (Barstow and Hruby 1971). Mechanisms of Appel-type reactions can be 
complex and more than one pathway can operate at the same time. The use of an Appel-
type reaction for the esterification of carboxylic acids has been mentioned in reviews 
(Appel 1975) without a clear reference to an original research article in this respect. 
Tetrachlorocarbon (CCl4) is listed as an ozone class 1 depletor (UNEP 1996) and has been 
phased out for many applications. Therefore, it seemed important to look for a substitute 
for CCl4. This was found in BrCCl3. The C-Br bond exhibits a lower dissociation energy 
than the C-Cl bond, and so the photochemically induced homolytic cleavage, producing 
the bromo radical, occurs at a longer wavelength than the C-Cl cleavage in CCl4. Also, 
BrCCl3 has a small dipole, so that it would be expected that BrCCl3is removed from the 
atmosphere more quickly than CCl4. Still, BrCCl3 has a half-life of 44 years in the 
atmosphere (Atkinson R. et al. 1992, Orkin and Kasimovskaya 1995), but it is not listed 
as a class 1 or class 2 ozone depletor. The Thiemann group started using BrCCl3 in 2010. 
In 2010, the Lautens group published the use of BrCCl3/PPh3 in the Appel reaction itself 
and in the transformation of alkanones and alkanals into the corresponding dichlorovinyl 
compounds (Newman et al. 2011). Before that, Clement and Soulen had shown that the 
reaction of acyl cyanides with PPh3/BrCCl3 leads to the corresponding 3,3-
dichloroacrylonitriles (Clement and Soulen 1976). Later, Thiemann et al. reported on the 
use of BrCCl3/PPh3 in the transformation of aldoximes and amides to nitriles (Y. Al Jasem 
et al. 2014) and on the use of BrCCl3/PPh3 in amidation reactions and the preparation of 
anhydrides from carboxylic acids (T. Thiemann et al. 2011, M. Al Azani et al. 2016). The 
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reaction could also be used to prepare esters and acyloximes. The reaction was utilized to 
prepare a number of cinnamyl esters, propionates, cinnamyl amides, and propionamides 
needed for as starting materials for further reactions (see below). 
When BrCCl3 was mixed with PPh3 in CH2Cl2 or in CH3CN a dark yellow solution 
developed after 20 min. of stirring at RT. When the acid component was added, the color 
disappeared rapidly. Addition of amine often led to a strongly exothermic reaction. When 
an alcohol was added for an esterification, the smell of hydrogen chloride emanated. A 
tertiary amine was not used as a proton scavenger. Initially, DBU was used, but the results 
were notbetter. Therefore, liberated HCl was driven off from time to time by putting a 
little vacuum onto the system. As the lab ran out of BrCCl3, also CCl4 was used in some 
of the experiments, as CCl4 was used in the classical type of Appel reaction. For the 
esterification, it was noted, however, that the yield was lower than when using BrCCl3. 
BrCCl3 reacts with PPh3 relatively quickly at RT., which can be followed by the change 
of color during the reaction. For a change of color in the reaction of CCl4 with PPh3, 
elevated temperature was needed, and this part of the Appel-type reaction was carried out 
in refluxing CH2Cl2, necessitating 45 min. Some of the cinnamic acids have poor 
solubility in CH2Cl2 – then CH3CN was used as solvent. In those cases CH3CN had to be 
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Scheme 10: Examples of the amidation of alkoxylated cinnamic acids in a modified 
Appel-type reaction 
 
3.3 Exploratory Reactions to Hydroxylated/Alkoxylated Phenylpropionic 
Acids 
The reaction from a cinnamic acid, a cinnamate, or a cinnamamide to a respective 
phenylpropionic acid, phenylpropionate or phenylpropionamide should proceed easily 
through hydrogenation of the double bond using hydrogen gas and a platinum or 
palladium catalyst (O’Connor 2011). There had been however a small fire in our 
laboratory in January 2013 resulting from the use of hydrogen gas and its exposure to dry 
catalyst. Normally, it is strongly recommended to flush the solution to be hydrogenated 
with inert gas before adding hydrogen.  
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As this was complicated with the current infrastructural setup, it was sought to 
derive the hydrogen in-situ, in the solution that was to be hydrogenated. Additionally, we 
wanted to use benzylic protective groups (PGs) in some of our synthetic strategies. These 
were to be removed at the end by hydrogenation, also. Most welcome was a selective, 
controlled hydrogenation process (double bond vs. debenzylation) with in situ generated 
hydrogen. From the literature, it could be seen that in-situ hydrogen production through 
the decomposition of formic acid (Garcia-Verdugo et al. 2006) had been explored 
previously. In addition, “hydrogen transfer” reactions (Zassinovich et al. 1997; Brieger 
and Nestrick 1975) are known, where no externally added hydrogen gas is necessary. 
Typical “hydrogen donors” can be ammonium formate (Paryzek et al. 2003), formic acid 
(Brunel 2007; Berthold 2002, Soltani et al. 2009), hydrazine (Imada et al. 2010) or silanes 
(Mandal and McMurray 2007).  
Many of the hydrogen transfer reactions, however, need specific catalysts that are 
not easy to obtain. When screening the literature, the most promising system for 
hydrogenating alkenes with in situ produced hydrogen seemed to be the one forwarded 
by D. B. Cordes et al. (Russo et al. 2011; Rousslang et al. 2011; Tran et al., 2009). D. B. 
Cordes used NaBH4, acetic acid (AcOH) in the presence of Pd/C with toluene as the 
solvent. From their work it was clear that halo substituents such as bromo and chloro 
substituents would be reductively removed, but the work did not investigate whether the 
system NaBH4, AcOH, Pd/C (cat.) would reductively cleave benzyl esters, benzyl ethers 
or benzyl amides to produce the free acids, alcohols and amines, respectively. 
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When NaBH4, CH3CO2H, Pd/C in the first O-debenzylation reactions, the O-
debenzylation, eg. From 31 to 32, did not proceed, even with an excess of reagent 
(Scheme 11). 
 
Scheme 11: O-Debenzylation of (2-(benzyloxy)ethyl)benzene does not proceed under 
the conditions 
 
This result gave an indication that NaBH4, CH3CO2H, Pd/C could be used as a 
reaction system that would allow to hydrogenate double bonds in the presence of benzyl 
ethers and benzyl esters. In order to assure this, hydrogenations of alkenes carrying O-
benzyl ether, O-benzyl ester and N-benzyl amide functions with this reducing agent. 
When a finely ground powder of NaBH4 is added to a mixture of alkene, acetic 
acid and Pd/C in toluene or benzene, fine gas bubbles appear immediately. The sodium 
borohydride reacts with the acetic acid, giving, apart from sodium acetate (36), hydrogen 
and borane. Borane (37), or its formed dimer, diborane (38), would then hydrolyse with 
the water introduced with the acetic acid and solvents to form boric acid (39) and further 
hydrogen (Scheme 12). The hydrogen thus produced in situ provides the reagent in the 
Pd/C catalyzed hydrogenation reaction of the alkenes. The life-time of the borane (37)/ 
diborane (38) produced in the reaction has not been ascertained and so great care must be 
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taken, as borane (37)/ diborane (38) are highly toxic, and a complete hydrolysis of the 
borane with completion of the hydrogenation of the alkenes has not been established.  
 
Scheme 12: Reaction sequences of NaBH4 in presence of CH3CO2H and water 
 
With NaBH4, CH3CO2H, Pd/C in toluene or benzene, alkenes 28 and 40, carrying 
O-benzyl ether functions and/or O-benzyl ester groups could be hydrogenated effectively 
without loss of the O-benzyl function. Multiple double bonds in a substrate are completely 
hydrogenated under the conditions as can be seen in the transformation of compound 40b 
to compound 42b. Ketones are not reduced with NaBH4, CH3CO2H, (cat.) Pd/C, evident 
in the conversions of 40a/40b to 42a/42b. Upon careful handling, even a carbaldehyde-
function can be retained in the reaction as can be seen in the transformation of 2-
benzyloxycinnamaldehyde (24) to 2-benzyloxyphenylpropionaldehyde (40c) with only 





Table 1: Reduction of alkenes carrying O-benzyl ester and/or O-benzyl ether functions 
 
 
                  It is known that also ammonia, ammonium acetate and pyridine suppress 
reductive O-debenzylation with hydrogen in the presence of Pd/C, while the 
hydrogenation of alkenes proceeds under the conditions (Sajiki 1995, Sajiki et al. 1997, 
Sajiki et al. 1998A, Sajiki et al. 1998B, Sajiki and Hirota 1998, Sajiki and Hirota 2003). 
63 
 
Also, Bartsch 1984, Pennings and Reinhoudt 1983, Fleet and Smith 1985). Shortly, the 
mechanistic reasoning behind the suppression of the O-debenzylation in our case is not 
clear. The accepted mechanism for the Pd (0) hydrogenative O-debenzylation is shown in 
Scheme 13. It must be noted that the reaction is taken place under heterogeneous 
conditions, while the mechanism does not consider this. It is believed that the reductive 
step D to E is significantly important to determine the character of the “Pd(0)” species 
and may depend on the reactive system (Scheme 13). 
 





Scheme 14: Hydrogenation of N-benzyl cinnamamides to N-benzyl 
phenylpropionamides 
 
Also, N-benzyl cinnamamides 30e – 30h were subjected to hydrogenation with 
NaBH4, CH3CO2H in the presence of cat. Pd/C to afford the corresponding N-benzyl 
phenylpropionamides 43a – 43d (Scheme 14). Due to the poor solubility of both 30g and 
30h compounds in toluene or benzene, their hydrogenation was carried out in a mixture 
of toluene and THF (1/1 v/v). No N-debenzylation was observed in the reactions. Overall, 
the stability of the benzyl protective group (Bn-PG) was found to be -NHBn; -
CH2OCH2Ph >  PhOCH2Ph  > -CO2CH2Ph, under the reaction conditions used. This could 
be seen when N-benzyl 4-methoxy-3-benzyloxycinnamamide 30h was subjected to 
prolonged reaction more than 36 hrs. with NaBH4, CH3CO2H, Pd/C in a solvent mixture 
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of toluene and THF (1:1 v/v), where the O-benzyl function was reductively cleaved as 


















Scheme 15: The hydrogenation of N-benzyl 4-methoxy-3-benzyloxycinnamide 
 
While we found that 2,5-dimethoxycinnamamides with secondary amines have 
low melting points, 2,5-dimethoxypropionamides with secondary amines are oils. 2,5-
Dimethoxypropionamides with primary amines such as with n-octylamine have higher 
melting points as they exhibit intermolecular hydrogen bonding. With N-benzyl 4-
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Finally, the use hydrogen in presence of Pd/C is an often used method to convert 
nitroarenes to anilines (Vanier 2007). Other hydrogen sources such as formic acid and 
decaborane with Pd/C have been used in the transformation (Berthold et al. 2002, Bae et 
al. 2000). Although it would not benefit our final target, some nitrated benzyl ethers and 
benzyl esters were subjected to the conditions used above. It was found that nitroarenes 
are reduced to anilines also with the system NaBH4 and CH3CO2H in the presence of cat. 
Pd/C. Here, benzyl 4-nitrobenzoate (45) could be converted cleanly to benzyl 4-
aminobenzoate (46). Furthermore, benzyl 3-nitrobenzyl ether (47) could be transformed 
to 3-aminobenzyl benzyl ether (48) (Scheme 10). However, in the case of both benzyl 2-
nitrobenzoate (49) and benzyl 2-nitrobenzyl ether (52), the benzyl group was removed 
reductively to give mixtures of anthranilic acid (51) and benzyl 2-aminobenzoate (50) and 
of 2-aminobenzyl benzyl ether (53) and 2-aminophenol (54), respectively (Scheme 11). 
Here, close proximity of the nitro group to the benzyl function leads to partial 
reductive cleavage of the latter. While the reduction of the nitro group can pass through a 
number of intermediates and can be mechanistically complex, it is believed that a reactive 
intermediate along the pathway from nitro- to amino-function leads to the reductive 
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Scheme 17: Reductive transformations of nitroarenes with benzyl functions in close 
proximity to the nitro group. 
 
In all, a way was found that could be used in our laboratory to hydrogenate alkenes 
without reduction of ester functionalities and with a control over whether a debenzylation 
would take place at the same time or not. The reaction was used later to perform clean 
two step reactions: hydrogenation of the double bond and subsequent debenzylation. The 
hydrogenation step was used for all phenylpropionates and phenylpropionamides 
produced in this thesis. The two-step reaction was used to prepare all the 3-hydroxy-4-
propionates and 3-hydroxy-4-methoxypropionamides in this thesis (see below). 
Interestingly, recently, P. R. Sultane et al. also reported on the use of NaBH4 in CH3OH 
in the presence of Pd/C as a convenient protocol for the deprotection of benzyl esters 
(Sultane et al. 2015). In the paper, it is noted that H2 is produced when NaBH4 is allowed 
to react with CH3OH. However, it is also well-known that NaBH4 in CH3OH reduces 
ketones and aldehydes, maybe predominantely in the form of NaBHx(OCH3)y (X = 1-3; 
Y = 1-3), so that here a combination of mechanisms can operate: hydrogenation with in 
situ created H2, reduction with in situ created BH3 or B2H6, and hydride transfer.  
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The combination of NaBH4 and a ruthenium salt such as RuCl3
.3H2O has also been 
used successfully in the hydrogenation of olefins in the presence of ester functions and 
benzyl ether groups, which are not affected (Sharma et al. 2007, Babler et al. 2011, Babler 
and White 2010). Also the combination of NaBH4 and catalytic amounts of cobalt salts 
are known to reduce alkenes to alkanes, but here also ester groups are reduced, so that 
these cases involve a completely mechanism of reduction as compared to the one 
operating when using NaBH4, AcOH, Pd/C. It must also be noted that our system does 
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Scheme 18: Attempted hydrogenation of cholesterol with NaBH4, AcOH in the 
presence of Pd/C. 
 
Importantly, however, also the cinnamates and cinnamic acids could hydrogenated 
with NaBH4, AcOH in the presence of Pd/C to the corresponding phenylpropionates and 
phenylpropionic acids, where the hydrogenation of the cinnamates could be achieved 
readily, while the cinnamic acids were sluggish in the reaction and reaction times were 
long (up to 3 days). So, it was beneficial to hydrogenate the cinnamate first, and then to 




Scheme 19:  Hydrogenation of cinnamates and cinnamic acids to phenyl- propionates 
and phenylpropionic acids with NaBH4, AcOH in presence of Pd/C. 
 
The phenylpropionic acids could then be transformed into amides or esters 
utilizing the modified Appel reaction (Scheme 20). 
 
Scheme 20:  Amidation of phenylpropionic acids by modified Appel reaction 
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3.4 Exploratory Reactions of Converting 1,4-dimethoxyphenylpropionates 
and 1,4-dimethoxyphenylpropionamides 
A number of different synthetic approaches are known to quinones from 
alkoxylated/hydroxylated benzenes (Abraham et al. 2011, Weaver and Pettus 2014). 
Common reagents used are cerium ammonium nitrate (CAN) (Jacob et al. 1976) and 
potassium dinitrosodisulfonate (Fremy’s salt) (Weaver and Pettus 2014). 
The conversion of 1,4-dimethoxybenzene to para-benzoquinones is almost always 
carried out with CAN, often using a mixture of CH3CN and H2O as solvent. The 2,5-
dimethoxypropionates and 2,5-dimethoxypropionamides facilely reacted to the 
corresponding para-benzoquinones (Table 2). Upon addition of the yellow, aqueous 
solution of CAN to the product in acetonitrile, the reaction mixture immediately turned 
orange-reddish. The orange-reddish component of the reaction mixture is a by-product, 
however, from which the oftentimes yellow (in solution) quinone can be separated by 
column chromatography.  
Sometimes, Rf values of starting material and product can be similar, but the 
product can be seen as more “UV intense” on the TLC. Also, the product, initially 
showing a faint yellow color on the TLC will turn brownish upon standing, probably due 
to a redox reaction of the quinone. From the column, the quinones are obtained as pale-
yellow to orange solids in the case of the secondary amides and as orange to reddish oils 
in case of the tertiary amides. Both carbonyl functions of the quinones invariably show a 




Table 2: Preparation of amidoethylquinones 
 




Scheme 21: Example of the preparation of a quinonylpropionate (Al-Azani et al. 2015) 
 
The process of Appel type reaction with 2,5-dimethoxycinnamic acid (27b) using 
PPh3/BrCCl3 as the reagent, hydrogenation of the Appel-type product using NaBH4-
AcOH-THF-toluene and subsequent oxidative demethylation with CAN in AcCN-H2O 
can also be used nicely to prepare quinones bound to a substructure by ester linkage as 
shown in Scheme 21. 
3.5 Exploratory Reactions of Converting 3-hydroxy-4-methoxyphenyl    
propionates and 3-hydroxy-4-methoxyphenylpropionamides 
When, the 3-hydroxy-4-methoxyphenylpropionamides were treated with CAN in 






Table 3: Conversion of 3-hydroxy-4-methoxyphenylpropionate and 3-hydroxy-4-







The conversion of the hydroxyl-methoxyarene to the methoxyquinone system is 
of interest and not trivial. Equally well, it could have been envisaged that an ortho-
quinone (minus methoxy group) would form, as there is some precedence for this as in 
















Scheme 22: Synthesis of isopsoralenquinone (Reed and Moore 1988). 
 
There are some examples, however, where an oxo group is introduced para to a 
hydroxy- or methoxy group upon reaction with CAN, if the para-position is available. 
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Scheme 25: Oxidation to chloromethoxybenzoquinone (Spyroudis 2000, Bruner et al. 
1995) 
 
Scheme 25 shows a typical example, where an oxo group is introduced by CAN 
into the 1,4-position to a methoxy group to give a p-quinone is the chloro-methoxy-
substituted arene 71, which is transformed to 72 (Spyroudis 2000, Bruner et al. 1995). 
The direct oxidation of phenols to para-quinones can also be achieved with 
salcomine/O2(Podlesny and Kozlowski 2012) and with O2 itself in the presence of a base 
(Danheiser et al. 1992) such as TBAF or KOBut. In all, the transformation from 3-
hydroxy-4-methoxyphenylpropionamides and 3-hydroxy-4-methoxyphenylpropionates 
to the corresponding methoxyquinones, pursued in this thesis, is worth a more 
comprehensive study. 
The UV-VIS spectra of the acquired quinones were measured in CH2Cl2 and 
CH3CN. No appreciable solvent effect was noted, however. Isolated quinones show an 
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intense absorption at λ = 250 nm and a weaker absorption band at λ = 305-310 nm (see 
Scheme 26). Quinones with a carbonyl substituent exhibit an intense absorption at λ = 
245 nm and a weaker absorption band at λ = 325 nm. The methoxy substituted quinones 
display an intense absorption at λ = 265 nm and a weaker absorption band at λ = 350 - 360 
nm, meaning that both absorption bands are shifted towards lower energy versus the 






























Figure 1: Electronic scheme of a p-quinone 
 
According to the literature, both absorptions that were observed are related to π- 
π* transitions. n-π* Transitions have been reported to be very weak and at longer 
wavelengths (400-500 nm and 650 nm, respectively) (Orlando et al. 1968, Kuboyama 





Scheme 26:  UV-VIS absorption data for selected quinones. 
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3.6 Preparation of Cholesteryl and Estradiol Derived Steroid Quinone 
Hybrids Utilizing the Above Reactions 
Finally, a number of steroid-quinone conjugates were prepared using the reactions 
studied and optimized above. Starting from 2,5-dimethoxybenzaldehyde (25a), a Wittig 
reaction produced dimethoxycinnamate 27b. 27b was subjected to hydrogenolysis using 
NaBH4, AcOH, Pd/C. The dimethoxyphenylpropionate obtained was hydrolysed to 57b 
(aq. NaOH, MeOH). It must be noted that during hydrolysis sodium salts can be obtained 
that are not completely soluble in the solvents mixture. One needs to take care not to lose 
this precipitated part. For instance, when hydrolyzing ethyl 4-benzyloxypropionate, which 
itself is an oil, in 10w%aq. NaOH/MeOH (2:1 v/v), it can be seen that after some time a 
solid forms which is the sodium 4-benzyloxypropionate. 2,5-Dimethoxypropanoic acid 
(57b) does not crystallize well from the aqueous solution, so that the ensuing mixture was 
extracted with ether and chloroform. A short column followed. Then, the 2,5-
dimethoxyphenylpropionic acid (57b) was esterified with cholesterol (55) using the 
modified Appel type reaction. Finally, the cholesteryl dimethoxyphenylpropionate 73 was 
oxidized with CAN in H2O/CH3CN to the cholesterol quinone hybrid 74. 3-Cholesteryl 
2,5-dimethoxypropionate (73) crystallizes slowly. Once crystallized, however, it is hard 
to dissolve in acetonitrile. Nevertheless, it is possible to add a small amount of 
dichloromethane that helps dissolves the steroidal ester, but is not detrimental to the 
progress of the reaction. More problematic is the reaction with 3-cholesteryl 2,5-
dimethoxybenzoate (76). Here, the addition of a small amount of CH2Cl2 still leads to an 
incomplete oxidation of the starting material. As reactions with CAN have been reported 
to proceed in CH3CN, THF, CH2Cl2 and even in alcohols, it was decided to run the 
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reaction in a mixture of CH3CN/CH2Cl2 that would be able to solubilize the starting 
material. Also, the reaction time was lengthened to 1h as the product seemed to be 
reasonably stable in the reaction medium (Scheme 27). 
 
Scheme 27: Overall reaction sequence to 3-cholesteryl 1,4-quinon-2-ylpropionate 
 
A similar sequence was carried out with 2,5-dimethoxybenzoic acid (75). 
Dimethoxybenzoic acid (75) was prepared by oxidation of 2,5-dimethoxybenzaldehyde 
(25a) with Ag2O (Janssen and Wilson 1956). Again, the esterification was carried out by 
modified Appel-type reaction. The oxidative demethylation reaction to the steroidal 
quinone 77 proceeded readily, but the compound was less stable during the column 
























Scheme 28:  Overall reaction sequence to 3-cholesteryl quinonylcarboxylate 
 
The reaction to the methoxyquinone-steroid conjugate was pursued through a 
number of synthetic routes. Initially, hydroxy group in 3-hydroxy-4-methoxy 
benzaldehyde (24a) was protected as the O-benzyl ether 25b. With the protected 
benzaldehyde, the Wittig reaction was carried out, the double bond hydrogenation of the 
cinnamate 28b, the hydrolysis to the cinnamic acid 41b and finally the hydrogenative 
debenzylation to 3-hydroxy-4-methoxyphenylpropionic acid (57c). Later on, a more 
direct route was taken without benzylation of the hydroxyl group. Initially, the 
benzylation was chosen as an early experiment of esterifying directly 3-hydroxy-4-
methoxycinnamic acid and 3-hydroxy-4-methoxyphenylpropionic acid gave only poor 
yields. This was to be circumvented by chosing the benzyl group. It was seen later on that 
the poor yield of the direct esterification of the non-protected phenolic acids was due to 
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moisture that they had retained as at the time they had been produced directly from their 
respective esters and had been obtained by acidification, filtration and air-drying of the 
product. Later, it was seen that the esterification of non-protected phenolic acids under 
the modified Appel reaction conditions proceeded in acceptable yields. The oxidative 
demethylation of compound 78 with CAN went without problem, and 79 was reasonably 






































R = Et (41b)
R = H (57a)
Ph3P=CHCO2Et, min. CHCl3A:
B: NaBH4, AcOH, toluene, Pd/C




















Scheme 29:  Overall reaction sequence to cholesteryl 5-methoxy-1,4-quinon-2-
ylpropionate  with different synthetic routes  
 
Similarly, the 3-methoxyestran-17β-yl 1,4-quinon-2-ylpropionate was produced. 
Estrone (80) was O-methylated at C3 (KOH, DMSO, CH3I) and then reduced to the 3-O-
methylestradiol (NaBH4, MeOH-Et2O). Modified Appel reaction with 2,5-
dimethoxycinnamic acid (27b) produced the steroidal cinnamate 82, which could be 
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hydrogenated (NaBH4, AcOH, Pd/C) to the steroidal phenylpropionate 83, which was 
























































Scheme 31: Structures of quinonylacrylic acid E3330 and quinonylacrylamide E3330-
amide (Zhang et al. 2013, Nyland et al. 2010). 
 
Lastly, it was tried to transform the dimethoxycinnamates and cinnamamides to 
the corresponding quinonylacrylates and quinonylacrylamides. Recently, some 
quinonylacrylates and quinonylacrylamides, such as quinonylacryl acid E3330 (85) and 
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E3330-amide (86) (Scheme 31), have been synthesized and found to be strong 
apurinic/apyrimidinic endonuclease 1 inhibitors. These proteins play a role in cellular 
redox regulation (Zhang et al. 2013). Nyland et al. had published a recent synthetic 
strategy to these via CAN oxidation the tetramethoxycinnamates. We have subjected the 
benzyl dimethoxycinnamamide 30b to CAN oxidation in CH3CN/H2O (Scheme 24). 
While the reaction proceeded as with the dimethoxypropionamides, showing in the TLC 
a pronounced strongly UV active product, column chromatographic separation only gave 
two small fractions, one yellowish one reddish, both of which showed to be a mixture, 
most likely of oligomers, where the vinylic moiety was no longer in evidence, but where 
methoxy groups could still be observed. 
 It may be that the main fraction reacted during the chromatographic separation on 
the column, which would speak for the slow diminishing of the intensity of a strongly 
yellow fraction associated with the created quinone. Nevertheless, the result also shows 
that there is at least some oligomerization during the oxidative reaction and that also there 
is no complete demethylation/oxidation. Why these results are different from those 
obtained by Nyland et al. is not yet clear, but perhaps the additive methoxy group in 
Nyland’s subtrate/productand/or the trisubstitution of the alkene moiety suppress 
oligomerization and the reactive decomposition of the product on silica. CAN is used as 
a polymerization initiator of polymerization reactions of acrylates and methacrylates 
(Deng et al. 2016, Yalinca et al. 2016, Xu et al. 2015), so that a possibility of 
oligomerization might have been expected. The polymerizations using CAN as an 
initiator, however, are usually run under less mild conditions than those used in the 
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attempted oxidation of 30b. Methyl quinonylacrylate, prepared electrochemically, has 
been shown to be quite reactive (Irngartiner and Stadler 1998). 
Quinonyl acrylates have also been synthesized from the corresponding 
dimethoxycinnamates with the combination of 4-iodophenxyacetic acid and Oxone® 
(Yakura et al. 2010).  As oxone is known also to hydroxylate tertiary carbons in steroidal 

















Scheme 32: 2,5-Dimethoxycinnamamide 30bdoes not oxidize smoothly of 
quinonylacrylate 
 
3-O-Methoxyestra-1,3,5(10)-trien-17β-yl 2,5-dimethoxycinnamate is still left as a 


















Also, with 3-O-methoxyestra-1,3,5(10)-trien-17β-yl 3.4-dimethoxyphenyl 
propionate (89) and 4-methoxyphenylpropionate (90), there are two further possible 














Scheme 34: Further molecules in stock. 
 
 
3.7 Bromination of The 3-hydroxy-4-methoxyphenylpropionamide and 3-
hydroxy-4-methoxyphenylpropionate Moieties As Prosthetic Groups of 
Steroids 
In the radiohalogenation of steroids, the selectivity of the reaction is important as 
well as the ease of manipulation and work-up of the product. In the most direct way, 
estrone and 3-O-methylestrone themselves have been brominated and iodinated. Here, it 
came to mixtures of 2-halo, 4-halo and 2,4-dihaloestrones, where the 3-hydroxy and the 
3-methoxy groups directed the halogen substituent into the ortho-position, the para-
position not being available. No halogenation of C16, α- to the 17-keto group could be 
noted, however. The mixture of compounds led to a complicated separation process at 
that time, where the dehalogenated estrones were selectively dehalogenated under 
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reductive conditions (Numazawa et al. 1985, Shiine 2009, Burmester et al. 2013). Clearly, 
a leaving group on the steroidal frame, including on the aromatic A-ring of an estradiol 
derived steroid, can lead to very selective halogenations (Oliveira el al. 2012, Oliveira et 
al. 2013, Thiemann et al. 2016).  On the other hand, often it is of advantage and easier to 
halogenate a prosthetic group linked to the steroid (Neto et al. 2012) or a substituent on 
the steroid (Neto 2011, Melo e Silva 2001). 
The 3-hydroxy-4-methoxyphenylpropionamides and 3-hydroxy-4-methoxy 
phenylpropionates, prepared and utilized above, seemed a suitable system to tag with a 
halogen as these are very electron rich systems. It would be very beneficial to use the 
same immediate structural precursor for a potential therapeutic (quinone system) and 
diagnostic (radiolabeled) chemical structure. The importance of the substitution pattern in 
43 is the hydroxyl function, which should have a very strong activating effect and should 
direct a further substituent into the ortho/para positions. The bromination of phenols has 
been achieved in a number of ways such as by direct bromination with bromine (de la 
Mare 1974), which, however, often produces polybrominated by-products and mixtures 
of regioisomers. N-Bromosuccinimide (NBS), bromination has been described under 
different conditions such as NBS/HBF4
.Et2O in CH3CN (Oberhauser 1997) and NBS in 
DMF (Mitchell et al. 1979). Thus, it was decided to try the bromination of the 3-hydroxy-
4-methoxyphenylpropionamides with N-bromosuccinimide (NBS). Radiolabelled N-
bromosuccinimide is known. R. Otto has communicated the use of 82Br-NBS (Otto 1985).       
The question remained how the directive effects of the methoxy, the hydroxyl and the 
alkyl function would balance each other. Work of the group of Carreño (Carreño et al. 
1997) has shown that in the bromination with N-bromosuccinimide (NBS), the phenolic 
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hydroxyl group in polar solvents such as CH3CN is para-directing, in non-polar solvents 
such as CS2 ortho-directing. Also, Carreño et al. showed that the hydroxyl group’s 
directivity was more important than that of the methoxy group. As the Thiemann group 
had some success using DMF as a solvent for bromination of arenes with NBS, DMF was 
used here, also. When N-octyl 3-hydroxy-4-methoxyphenylpropionamide (43n) was 
reacted with NBS in DMF at RT, mono-brominated compound 91 was produced, where 



















Scheme 35: Monobromination of N-octyl 3-hydroxy-4-methoxyphenylpropionamide 
 
The 1H NMR spectrum shows two singlets at δ 6.82 ppm and 6.96 ppm, 
respectively. The 13C NMR spectrum agrees with that predicted by the algorithm 























calculated (with software embedded in ChemDraw Ultra) experimental 13C NMR data  





With an excess of NBS, dibromination takes place as can be seen in the reaction 
of N-benzyl 3-hydroxy-4-methoxyphenylpropionamide (43m), which could be 
transformed selectively to N-benzyl 2,6-dibromo-3-hydroxy-4-methoxyphenylpropion 
amide (92). Nevertheless, the non activated benzyl group was not brominated under the 
conditions so that selective mono- and subsequently dibromination of the more activated 

















Scheme 37: Selective dibromination of N-benzyl 3-hydroxy-4-
methoxyphenylpropionamide 
 
It has not been tried to connect the 3-hydroxy-4-methoxyphenylethyl moiety to an 
estradiol derived system, yet, eg., by ester or amide bond, as in compound 93 (Scheme 
38). Here, the monobromination has to be carried out with great care as a second bromo 















Chapter 4: Conclusions and Outlook 
In this study, four steroidalquinone conjugates were prepared: 3-Cholesteryl 1,4-
quinon-2-ylpropionate (74), 3-Cholesteryl quinonylcarboxylate (77), Cholesteryl 5-
methoxy-1,4-quinon-2-ylpropionate (79) and 3-Methoxyestra-1,3,5(10)-trien-17β-yl 2,5-
(E)-dimethoxycinnamate (82) 
To achieve this, hydroxylated and alkoxylated cinnamic acids were prepared, 
either in a one-step Wittig-olefination-hydrolysis reaction or by a two-step procedure of 
Wittig reaction and subsequent hydrolysis (aq. NaOH-CH3OH). 
Next, the esterification and amidation of these cinnamic acids were studied under 
modified Appel reaction conditions, where O-benzyl and N-benzyl protective groups were 
introduced into the molecules. It was found that PPh3/BrCCl3 could be used effectively 
for the amidation and esterifications of carboxylic acids in general. This study must be 
seen as a continuation of ongoing research into this reaction in Thiemann group.  
Then, the hydrogenation of the cinnamates and cinnamides was studied, where the 
hydrog en needed for the reaction was produced in situ. The reactions were investigated 
in regard to the selectivity of the hydrogenation reaction over the reductive debenzylation. 
Thereafter, it was studied under which conditions the hydrogenative debenzylation would 
succeed using the same system (NaBH4, AcOH, Pd/C, toluene or benzene). It was found 
that alkene hydrogenation of activated double substituted alkenes works selectively over 
O-debenzylation. With an excess of reagent and under longer reaction times, O-
debenzylation proceeds, also, while N-debenzylation does not succeed. 
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Further, the oxidation of 2,5-dimethoxyphenylpropionamides and 2,5-dimethoxy 
phenylpropionates, prepared above, to the respective quinones was carried out. 
Thereafter, the focus was on the use of the 3-hydroxy-4-methoxyphenylpropionamides 
and 3-hydroxy-4-methoxypropionates, prepared above. Dealkylation/oxidation with 
CAN was found to lead to methoxy-substituted quinones. These reactions were combined 
to synthesize four steroidal quinone conjugates. 
Finally, the selective bromination of the 3-hydroxy-4-methoxypropionamides was 
studied, where the 3-hydroxy-4-methoxypropionamide is seen as a potential prosthetic 
group joined to the steroids. It was found that the bromine enters the molecule selectively 
para to the hydroxyl function. With excess NBS, a second bromination of the 3-hydroxy-
4-methoxypropionamide is achieved. No bromination is found in the N-benzyl group or 
on the carbon α to the amide function. 
The strategies that were finally followed and the reactions that were used were 
governed by the laboratory infrastructure in place and the type of reactions that the 
laboratory was laid out for. So, the work with and purification of strongly corrosive 
reagents such as acid halides, thionyl chloride, sulfuryl chloride or phosphorus halides 
were avoided as much as possible. Therefore, the work on the Appel type reactions with 
PPh3/BrCCl3 had to be expanded upon to use it to furnish ester and amide linkages. The 
employment of external hydrogen gas was avoided – therefore the use of the reaction 
system NaBH4, AcOH, Pd/C had to be studied further in view of deprotection of O-benzyl 
protective groups (PGs) in relation to alkene hydrogenation. Also, the utilization of 
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bromine was to be avoided in our laboratory – therefore, the use of NBS was studied 
exclusively in the bromination reactions. 
Difficulties to modify some reactions to the available infrastructure and which 
would have been important for a better success of the thesis, could not be overcome. One 
such critical reaction was the preparation of steroidal amines, which would have involved 
the reduction of steroidal oximes (Ribeiro Morais 2006, Ribeiro Morais and Thiemann 
2012), the addition of trimethylsilyl cyanide with subsequent reduction (Ribeiro Morais 
2006, Ribeiro Morais and Thiemann 2012) or the work and purification of azides and 
subsequent reduction. Some of this was not attempted, some of this did not lead to good 
results. Thus, 3-O-methylestrone oxime was synthesized. Other oximes were prepared as 
test compounds for the reduction to amines, including cinnamaldehyde oxime, of which 
an X-ray crystal structure was published (Bugenhagen et al. 2015).  
It would very important to expand the work to include more estrane-derived 
steroidal-quinone conjugates. Here, it would be beneficial to proceed via the 17β-
aminoestranyl compounds 94 or the 17α-aminomethylestradiols 95 (Ribeiro Morais 2006, 
Ribeiro Morais and Thiemann 2012) to end with a steroid-quinone conjugate where the 
quinone is linked to the steroid via an amide bond. Also, it would be essential to study the 
bromination of steroidal 5-hydroxy-4-methoxyphenylpropionamides and steroidal 5-
hydroxy-4-methoxyphenylpropionates, where the estradiol derived structure should either 
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Scheme 39:  Interesting aminoestranes as future starting materials for steroid-quinone 
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IR Spectrum of 2-methoxy-5-(3-oxo-3-(piperidin-1-yl)propyl)cyclohexa-2,5-diene-
1,4-dione 
   














































































IR spectrum of 3-(3-(benzyloxy)-4-methoxyphenyl)-N,N-dipropylpropanamide
 





































































































































































 IR spectrum of N-benzyl-3-(4-methoxy-3,6-dioxocyclohexa-1,4-dien-1-yl) 
propanamide 
  
















































































































































































H1-1H-NMR spectrum of N-Octyl 5-methoxy-1,4-quinon-2-ylpropionamide 64d 
H1-NUHA-29-03-2016






































































13C-NMR spectrum  for  N-Octyl 5-methoxy-1,4-quinon-2-ylpropionamide 64d 
C13-NUHA-29-03-2016


































































































































































































































































































































































































1H-NMR spectrum for 3-Cholesteryl 2,5-dimethoxyphenylpropionate 73 
 
 
        13C-NMR spectrum for 3-Cholesteryl 2,5-dimethoxyphenylpropionate 73 
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      1H- NMR spectrum for 3-Cholesteryl quinonylcarboxylate 77
H1-NUHA-2-3-2016





































































      13C- NMR spectrum for 3-Cholesteryl quinonylcarboxylate 77 
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1H-NMR spectrum for  3-Cholesteryl 3-hydroxy-4-methoxy phenyl propionate 78 
 
 










































13C-NMR spectrum for 3-Cholesteryl-5-methoxy-1,4-quinon-2-ylpropionate 79  
 
 
































































































































































   1H spectrum for 3-(3-(benzyloxy)-4-methoxyphenyl)-N-octylpropanamide 
 
 
 
 
 
 
 
 
 
 
 
 
